1
|
Prylutska S, Grebinyk A, Ponomarenko S, Gövem D, Chumachenko V, Kutsevol N, Petrovsky M, Ritter U, Frohme M, Piosik J, Prylutskyy Y. Toxicity of Water-Soluble D-g-PNIPAM Polymers in a Complex with Chemotherapy Drugs and Mechanism of Their Action In Vitro. Int J Mol Sci 2024; 25:3069. [PMID: 38474314 DOI: 10.3390/ijms25053069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2024] [Revised: 02/27/2024] [Accepted: 03/03/2024] [Indexed: 03/14/2024] Open
Abstract
The application of a biocompatible polymer nanocarrier can provide target delivery to tumor tissues, improved pharmacokinetics, controlled drug release, etc. Therefore, the proposed strategy was to use the water-soluble star-like copolymers with a Dextran core and Poly(N-isopropylacrylamide) grafts (D-g-PNIPAM) for conjugation with the widely used chemotherapy drugs in oncology-Cisplatin (Cis-Pt) and Doxorubicin (Dox). The molecular characteristics of the copolymer were received using size-exclusion chromatography. The physicochemical characterization of the D-g-PNIPAM-Cis-Pt (or Dox) nanosystem was conducted using dynamic light scattering and FTIR spectroscopy. Using traditional biochemical methods, a comparative analysis of the enhancement of the cytotoxic effect of free Cis-Pt and Dox in combination with D-g-PNIPAM copolymers was performed in cancer cells of the Lewis lung carcinoma line, which are both sensitive and resistant to Dox; in addition, the mechanism of their action in vitro was evaluated.
Collapse
Affiliation(s)
- Svitlana Prylutska
- Department of Plants Physiology, Biochemistry and Bioenergetics, National University of Life and Environmental Sciences of Ukraine, 03041 Kyiv, Ukraine
| | - Anna Grebinyk
- Deutsches Elektronen-Synchrotron DESY, Platanenallee 6, 15738 Zeuthen, Germany
- Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, 15745 Wildau, Germany
| | - Stanislav Ponomarenko
- Department of Biophysics and Neurobiology, Department of Chemistry, Taras Shevchenko National University of Kyiv, 01601 Kyiv, Ukraine
| | - Defne Gövem
- Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, 15745 Wildau, Germany
| | - Vasyl Chumachenko
- Department of Biophysics and Neurobiology, Department of Chemistry, Taras Shevchenko National University of Kyiv, 01601 Kyiv, Ukraine
| | - Nataliya Kutsevol
- Department of Biophysics and Neurobiology, Department of Chemistry, Taras Shevchenko National University of Kyiv, 01601 Kyiv, Ukraine
| | - Mykola Petrovsky
- Department of Biophysics and Neurobiology, Department of Chemistry, Taras Shevchenko National University of Kyiv, 01601 Kyiv, Ukraine
| | - Uwe Ritter
- Institute of Chemistry and Biotechnology, Technical University of Ilmenau, 98693 Ilmenau, Germany
| | - Marcus Frohme
- Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, 15745 Wildau, Germany
| | - Jacek Piosik
- Intercollegiate Faculty of Biotechnology, University of Gdańsk and Medical University of Gdańsk, 80-307 Gdańsk, Poland
| | - Yuriy Prylutskyy
- Department of Biophysics and Neurobiology, Department of Chemistry, Taras Shevchenko National University of Kyiv, 01601 Kyiv, Ukraine
| |
Collapse
|
2
|
Delacher M, Schmidleithner L, Simon M, Stüve P, Sanderink L, Hotz-Wagenblatt A, Wuttke M, Schambeck K, Ruhland B, Hofmann V, Bittner S, Ritter U, Pant A, Helbich SS, Voss M, Lemmermann NA, Bessiri-Schake L, Bohn T, Eigenberger A, Menevse AN, Gebhard C, Strieder N, Abken H, Rehli M, Huehn J, Beckhove P, Hehlgans T, Junger H, Geissler EK, Prantl L, Werner JM, Schmidl C, Brors B, Imbusch CD, Feuerer M. The effector program of human CD8 T cells supports tissue remodeling. J Exp Med 2024; 221:e20230488. [PMID: 38226976 DOI: 10.1084/jem.20230488] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2023] [Revised: 10/19/2023] [Accepted: 12/06/2023] [Indexed: 01/17/2024] Open
Abstract
CD8 T lymphocytes are classically viewed as cytotoxic T cells. Whether human CD8 T cells can, in parallel, induce a tissue regeneration program is poorly understood. Here, antigen-specific assay systems revealed that human CD8 T cells not only mediated cytotoxicity but also promoted tissue remodeling. Activated CD8 T cells could produce the epidermal growth factor receptor (EGFR)-ligand amphiregulin (AREG) and sensitize epithelial cells for enhanced regeneration potential. Blocking the EGFR or the effector cytokines IFN-γ and TNF could inhibit tissue remodeling. This regenerative program enhanced tumor spheroid and stem cell-mediated organoid growth. Using single-cell gene expression analysis, we identified an AREG+, tissue-resident CD8 T cell population in skin and adipose tissue from patients undergoing abdominal wall or abdominoplasty surgery. These tissue-resident CD8 T cells showed a strong TCR clonal relation to blood PD1+TIGIT+ CD8 T cells with tissue remodeling abilities. These findings may help to understand the complex CD8 biology in tumors and could become relevant for the design of therapeutic T cell products.
Collapse
Affiliation(s)
- Michael Delacher
- Leibniz Institute for Immunotherapy , Regensburg, Germany
- Chair for Immunology, University Regensburg , Regensburg, Germany
- Institute of Immunology, University Medical Center Mainz , Mainz, Germany
- Research Center for Immunotherapy, University Medical Center Mainz , Mainz, Germany
| | - Lisa Schmidleithner
- Leibniz Institute for Immunotherapy , Regensburg, Germany
- Chair for Immunology, University Regensburg , Regensburg, Germany
| | - Malte Simon
- Leibniz Institute for Immunotherapy , Regensburg, Germany
- Faculty of Biosciences, Heidelberg University , Heidelberg, Germany
- Division of Applied Bioinformatics, German Cancer Research Center, Heidelberg, Germany
| | - Philipp Stüve
- Leibniz Institute for Immunotherapy , Regensburg, Germany
- Chair for Immunology, University Regensburg , Regensburg, Germany
| | - Lieke Sanderink
- Leibniz Institute for Immunotherapy , Regensburg, Germany
- Chair for Immunology, University Regensburg , Regensburg, Germany
| | - Agnes Hotz-Wagenblatt
- Core Facility Omics IT and Data Management, German Cancer Research Center , Heidelberg, Germany
| | - Marina Wuttke
- Leibniz Institute for Immunotherapy , Regensburg, Germany
- Chair for Immunology, University Regensburg , Regensburg, Germany
| | - Kathrin Schambeck
- Leibniz Institute for Immunotherapy , Regensburg, Germany
- Chair for Immunology, University Regensburg , Regensburg, Germany
| | - Brigitte Ruhland
- Leibniz Institute for Immunotherapy , Regensburg, Germany
- Chair for Immunology, University Regensburg , Regensburg, Germany
| | - Veronika Hofmann
- Leibniz Institute for Immunotherapy , Regensburg, Germany
- Chair for Immunology, University Regensburg , Regensburg, Germany
| | - Sebastian Bittner
- Leibniz Institute for Immunotherapy , Regensburg, Germany
- Chair for Immunology, University Regensburg , Regensburg, Germany
| | - Uwe Ritter
- Leibniz Institute for Immunotherapy , Regensburg, Germany
- Chair for Immunology, University Regensburg , Regensburg, Germany
| | - Asmita Pant
- Leibniz Institute for Immunotherapy , Regensburg, Germany
- Chair for Immunology, University Regensburg , Regensburg, Germany
| | - Sara Salome Helbich
- Institute of Immunology, University Medical Center Mainz , Mainz, Germany
- Research Center for Immunotherapy, University Medical Center Mainz , Mainz, Germany
| | - Morten Voss
- Institute of Immunology, University Medical Center Mainz , Mainz, Germany
- Research Center for Immunotherapy, University Medical Center Mainz , Mainz, Germany
| | - Niels A Lemmermann
- Research Center for Immunotherapy, University Medical Center Mainz , Mainz, Germany
- Institute of Virology, University Medical Center Mainz , Mainz, Germany
- Institute of Virology, University of Bonn , Bonn, Germany
| | - Lisa Bessiri-Schake
- Institute of Immunology, University Medical Center Mainz , Mainz, Germany
- Research Center for Immunotherapy, University Medical Center Mainz , Mainz, Germany
| | - Toszka Bohn
- Institute of Immunology, University Medical Center Mainz , Mainz, Germany
- Research Center for Immunotherapy, University Medical Center Mainz , Mainz, Germany
| | - Andreas Eigenberger
- Department of Plastic, Hand- and Reconstructive Surgery, University Hospital Regensburg, Regensburg, Germany
| | - Ayse Nur Menevse
- Leibniz Institute for Immunotherapy , Regensburg, Germany
- Chair for Interventional Immunology, University Regensburg , Regensburg, Germany
| | | | | | - Hinrich Abken
- Leibniz Institute for Immunotherapy , Regensburg, Germany
- Chair for Genetic Immunotherapy, University Regensburg , Regensburg, Germany
| | - Michael Rehli
- Leibniz Institute for Immunotherapy , Regensburg, Germany
- Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany
| | - Jochen Huehn
- Department of Experimental Immunology, Helmholtz Centre for Infection Research, Braunschweig, Germany
- Hannover Medical School , Hannover, Germany
- RESIST, Cluster of Excellence 2155, Hannover Medical School , Hannover, Germany
| | - Philipp Beckhove
- Leibniz Institute for Immunotherapy , Regensburg, Germany
- Chair for Interventional Immunology, University Regensburg , Regensburg, Germany
- Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany
| | - Thomas Hehlgans
- Leibniz Institute for Immunotherapy , Regensburg, Germany
- Chair for Immunology, University Regensburg , Regensburg, Germany
| | - Henrik Junger
- Department of Surgery, University Hospital Regensburg, Regensburg, Germany
| | - Edward K Geissler
- Department of Surgery, University Hospital Regensburg, Regensburg, Germany
| | - Lukas Prantl
- Department of Plastic, Hand- and Reconstructive Surgery, University Hospital Regensburg, Regensburg, Germany
| | - Jens M Werner
- Department of Surgery, University Hospital Regensburg, Regensburg, Germany
| | | | - Benedikt Brors
- Faculty of Biosciences, Heidelberg University , Heidelberg, Germany
- Faculty of Medicine Heidelberg, Heidelberg University , Heidelberg, Germany
- Division of Applied Bioinformatics, German Cancer Research Center, Heidelberg, Germany
- National Center for Tumor Diseases , Heidelberg, Germany
- German Cancer Consortium, German Cancer Research Center , Heidelberg, Germany
| | - Charles D Imbusch
- Institute of Immunology, University Medical Center Mainz , Mainz, Germany
- Research Center for Immunotherapy, University Medical Center Mainz , Mainz, Germany
- Division of Applied Bioinformatics, German Cancer Research Center, Heidelberg, Germany
| | - Markus Feuerer
- Leibniz Institute for Immunotherapy , Regensburg, Germany
- Chair for Immunology, University Regensburg , Regensburg, Germany
| |
Collapse
|
3
|
Stüve P, Nerb B, Harrer S, Wuttke M, Feuerer M, Junger H, Eggenhofer E, Lungu B, Laslau S, Ritter U. Analysis of organoid and immune cell co-cultures by machine learning-empowered image cytometry. Front Med (Lausanne) 2024; 10:1274482. [PMID: 38298516 PMCID: PMC10827864 DOI: 10.3389/fmed.2023.1274482] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2023] [Accepted: 11/24/2023] [Indexed: 02/02/2024] Open
Abstract
Organoids are three-dimensional (3D) structures that can be derived from stem cells or adult tissue progenitor cells and exhibit an extraordinary ability to autonomously organize and resemble the cellular composition and architectural integrity of specific tissue segments. This feature makes them a useful tool for analyzing therapeutical relevant aspects, including organ development, wound healing, immune disorders and drug discovery. Most organoid models do not contain cells that mimic the neighboring tissue’s microenvironment, which could potentially hinder deeper mechanistic studies. However, to use organoid models in mechanistic studies, which would enable us to better understand pathophysiological processes, it is necessary to emulate the in situ microenvironment. This can be accomplished by incorporating selected cells of interest from neighboring tissues into the organoid culture. Nevertheless, the detection and quantification of organoids in such co-cultures remains a major technical challenge. These imaging analysis approaches would require an accurate separation of organoids from the other cell types in the co-culture. To efficiently detect and analyze 3D organoids in co-cultures, we developed a high-throughput imaging analysis platform. This method integrates automated imaging techniques and advanced image processing tools such as grayscale conversion, contrast enhancement, membrane detection and structure separation. Based on machine learning algorithms, we were able to identify and classify 3D organoids within dense co-cultures of immune cells. This procedure allows a high-throughput analysis of organoid-associated parameters such as quantity, size, and shape. Therefore, the technology has significant potential to advance contextualized research using organoid co-cultures and their potential applications in translational medicine.
Collapse
Affiliation(s)
- Philipp Stüve
- Division of Immunology, LIT – Leibniz Institute for Immunotherapy, Regensburg, Germany
| | - Benedikt Nerb
- Division of Immunology, LIT – Leibniz Institute for Immunotherapy, Regensburg, Germany
- Chair for Immunology, University of Regensburg, Regensburg, Germany
| | - Selina Harrer
- Division of Immunology, LIT – Leibniz Institute for Immunotherapy, Regensburg, Germany
| | - Marina Wuttke
- Division of Immunology, LIT – Leibniz Institute for Immunotherapy, Regensburg, Germany
| | - Markus Feuerer
- Division of Immunology, LIT – Leibniz Institute for Immunotherapy, Regensburg, Germany
- Chair for Immunology, University of Regensburg, Regensburg, Germany
| | - Henrik Junger
- Department of Surgery, University Hospital Regensburg, Regensburg, Germany
| | - Elke Eggenhofer
- Department of Surgery, University Hospital Regensburg, Regensburg, Germany
| | | | | | - Uwe Ritter
- Division of Immunology, LIT – Leibniz Institute for Immunotherapy, Regensburg, Germany
- Chair for Immunology, University of Regensburg, Regensburg, Germany
| |
Collapse
|
4
|
Radivoievych A, Prylutska S, Zolk O, Ritter U, Frohme M, Grebinyk A. Comparison of Sonodynamic Treatment Set-Ups for Cancer Cells with Organic Sonosensitizers and Nanosonosensitizers. Pharmaceutics 2023; 15:2616. [PMID: 38004594 PMCID: PMC10674572 DOI: 10.3390/pharmaceutics15112616] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2023] [Revised: 10/31/2023] [Accepted: 11/07/2023] [Indexed: 11/26/2023] Open
Abstract
Cancer sonodynamic therapy (SDT) is the therapeutic strategy of a high-frequency ultrasound (US) combined with a special sonosensitizer that becomes cytotoxic upon US exposure. The growing number of newly discovered sonosensitizers and custom US in vitro treatment solutions push the SDT field into a need for systemic studies and reproducible in vitro experimental set-ups. In the current research, we aimed to compare two of the most used and suitable SDT in vitro set-ups-"sealed well" and "transducer in well"-in one systematic study. We assessed US pressure, intensity, and temperature distribution in wells under US irradiation. Treatment efficacy was evaluated for both set-ups towards cancer cell lines of different origins, treated with two promising sonosensitizer candidates-carbon nanoparticle C60 fullerene (C60) and herbal alkaloid berberine. C60 was found to exhibit higher sonotoxicity toward cancer cells than berberine. The higher efficacy of sonodynamic treatment with a "transducer in well" set-up than a "sealed well" set-up underlined its promising application for SDT in vitro studies. The "transducer in well" set-up is recommended for in vitro US treatment investigations based on its US-field homogeneity and pronounced cellular effects. Moreover, SDT with C60 and berberine could be exploited as a promising combinative approach for cancer treatment.
Collapse
Affiliation(s)
- Aleksandar Radivoievych
- Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745 Wildau, Germany; (A.R.); (A.G.)
- Faculty of Health Sciences, Joint Faculty of the Brandenburg University of Technology Cottbus-Senftenberg, The Brandenburg Medical School Theodor Fontane and the University of Potsdam, 14476 Potsdam, Germany;
| | - Svitlana Prylutska
- Department of Plants Physiology, Biochemistry and Bioenergetics, National University of Life and Environmental Science of Ukraine, Heroyiv Oborony Str., 15, 03041 Kyiv, Ukraine;
| | - Oliver Zolk
- Faculty of Health Sciences, Joint Faculty of the Brandenburg University of Technology Cottbus-Senftenberg, The Brandenburg Medical School Theodor Fontane and the University of Potsdam, 14476 Potsdam, Germany;
- Institute of Clinical Pharmacology, Brandenburg Medical School, Immanuel Klinik Ruedersdorf, 15562 Ruedersdorf, Germany
| | - Uwe Ritter
- Institute of Chemistry and Biotechnology, Technical University of Ilmenau, 98693 Ilmenau, Germany;
| | - Marcus Frohme
- Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745 Wildau, Germany; (A.R.); (A.G.)
| | - Anna Grebinyk
- Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745 Wildau, Germany; (A.R.); (A.G.)
- Deutsches Elektronen-Synchrotron DESY, Platanenallee 6, 15738 Zeuthen, Germany
| |
Collapse
|
5
|
Finkelmeyer SJ, Askins EJ, Eichhorn J, Ghosh S, Siegmund C, Täuscher E, Dellith A, Hupfer ML, Dellith J, Ritter U, Strzalka J, Glusac K, Schacher FH, Presselt M. Tailoring the Weight of Surface and Intralayer Edge States to Control LUMO Energies. Adv Mater 2023; 35:e2305006. [PMID: 37572365 DOI: 10.1002/adma.202305006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/26/2023] [Revised: 07/27/2023] [Indexed: 08/14/2023]
Abstract
The energies of the frontier molecular orbitals determine the optoelectronic properties in organic films, which are crucial for their application, and strongly depend on the morphology and supramolecular structure. The impact of the latter two properties on the electronic energy levels relies primarily on nearest-neighbor interactions, which are difficult to study due to their nanoscale nature and heterogeneity. Here, an automated method is presented for fabricating thin films with a tailored ratio of surface to bulk sites and a controlled extension of domain edges, both of which are used to control nearest-neighbor interactions. This method uses a Langmuir-Schaefer-type rolling transfer of Langmuir layers (rtLL) to minimize flow during the deposition of rigid Langmuir layers composed of π-conjugated molecules. Using UV-vis absorption spectroscopy, atomic force microscopy, and transmission electron microscopy, it is shown that the rtLL method advances the deposition of multi-Langmuir layers and enables the production of films with defined morphology. The variation in nearest-neighbor interactions is thus achieved and the resulting systematically tuned lowest unoccupied molecular orbital (LUMO) energies (determined via square-wave voltammetry) enable the establishment of a model that functionally relates the LUMO energies to a morphological descriptor, allowing for the prediction of the range of accessible LUMO energies.
Collapse
Affiliation(s)
- Sarah Jasmin Finkelmeyer
- Leibniz Institute of Photonic Technology (IPHT), Albert-Einstein-Str. 9, 07745, Jena, Germany
- Institute of Physical Chemistry, Friedrich Schiller University Jena, Helmholtzweg 4, 07743, Jena, Germany
| | - Erik J Askins
- Department of Chemistry, University of Illinois Chicago, 845 West Taylor Street, Chicago, Illinois, 60607, USA
- Chemical Sciences and Engineering Division, Argonne National Laboratory, 9700 S. Cass Avenue, Lemont, Illinois, 60439, USA
| | - Jonas Eichhorn
- Institute of Organic Chemistry and Macromolecular Chemistry (IOMC), Friedrich-Schiller-University Jena, Humboldtstraße 10, 07743, Jena, Germany
| | - Soumik Ghosh
- Leibniz Institute of Photonic Technology (IPHT), Albert-Einstein-Str. 9, 07745, Jena, Germany
- Institute of Physical Chemistry, Friedrich Schiller University Jena, Helmholtzweg 4, 07743, Jena, Germany
- sciclus GmbH & Co. KG, Moritz-von-Rohr-Str. 1a, 07745, Jena, Germany
| | - Carmen Siegmund
- Institute for Chemistry and Biotechnology, Ilmenau University of Technology, 98684, Ilmenau, Germany
| | - Eric Täuscher
- Institute for Chemistry and Biotechnology, Ilmenau University of Technology, 98684, Ilmenau, Germany
| | - Andrea Dellith
- Leibniz Institute of Photonic Technology (IPHT), Albert-Einstein-Str. 9, 07745, Jena, Germany
| | - Maximilian L Hupfer
- Leibniz Institute of Photonic Technology (IPHT), Albert-Einstein-Str. 9, 07745, Jena, Germany
| | - Jan Dellith
- Leibniz Institute of Photonic Technology (IPHT), Albert-Einstein-Str. 9, 07745, Jena, Germany
| | - Uwe Ritter
- Institute for Chemistry and Biotechnology, Ilmenau University of Technology, 98684, Ilmenau, Germany
| | - Joseph Strzalka
- X-Ray Science Division, Argonne National Laboratory, 9700 S. Cass Avenue, Lemont, IL, 60439, USA
| | - Ksenija Glusac
- Department of Chemistry, University of Illinois Chicago, 845 West Taylor Street, Chicago, Illinois, 60607, USA
- Chemical Sciences and Engineering Division, Argonne National Laboratory, 9700 S. Cass Avenue, Lemont, Illinois, 60439, USA
| | - Felix H Schacher
- Institute of Organic Chemistry and Macromolecular Chemistry (IOMC), Friedrich-Schiller-University Jena, Humboldtstraße 10, 07743, Jena, Germany
- Jena Center for Soft Matter (JCSM), Friedrich-Schiller-University Jena, Philosophenweg 7, 07743, Jena, Germany
- Center for Energy and Environmental Chemistry Jena (CEEC Jena), Friedrich Schiller University Jena, Philosophenweg 7a, 07743, Jena, Germany
| | - Martin Presselt
- Leibniz Institute of Photonic Technology (IPHT), Albert-Einstein-Str. 9, 07745, Jena, Germany
- sciclus GmbH & Co. KG, Moritz-von-Rohr-Str. 1a, 07745, Jena, Germany
- Center for Energy and Environmental Chemistry Jena (CEEC Jena), Friedrich Schiller University Jena, Philosophenweg 7a, 07743, Jena, Germany
| |
Collapse
|
6
|
Motuziuk O, Nozdrenko D, Prylutska S, Vareniuk I, Bogutska K, Braniuk S, Korotkyi O, Prylutskyy Y, Ritter U, Piosik J. The effect of C 60 fullerene on the mechanokinetics of muscle gastrocnemius contraction in chronically alcoholized rats. Heliyon 2023; 9:e18745. [PMID: 37554800 PMCID: PMC10404780 DOI: 10.1016/j.heliyon.2023.e18745] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2023] [Revised: 07/13/2023] [Accepted: 07/26/2023] [Indexed: 08/10/2023] Open
Abstract
The C60 fullerene effect (oral administration at a dose of 1 mg kg-1) on the selected biomechanical parameters of muscle gastrocnemius contraction, biochemical indicators of blood and muscle tissue as well as histological changes in rat muscle tissue after chronic alcoholization for 3, 6 and 9 months was studied in detail. Water-soluble C60 fullerenes were shown to reduce the pathological processes development in the muscle apparatus by an average of (35-40)%. In particular, they reduced the time occurrence of fatigue processes in muscle during the long-term development of alcoholic myopathy and inhibited oxidative processes in muscle, thereby preventing its degradation. These findings open up the possibility of using C60 fullerenes as potent antioxidants for the correction of the pathological conditions of the muscle system arising from alcohol intoxication.
Collapse
Affiliation(s)
- Olexandr Motuziuk
- Faculty of Biology and Forestry, Lesya Ukrainka Volyn National University, Lutsk, 43025, Ukraine
- Department of Biophysics and Medical Informatics, ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, Kyiv, 01601, Ukraine
| | - Dmytro Nozdrenko
- Department of Biophysics and Medical Informatics, ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, Kyiv, 01601, Ukraine
| | - Svitlana Prylutska
- Department of Physiology, Plant Biochemistry and Bioenergetics, Faculty of Plant Protection, Biotechnology and Ecology, National University of Life and Environmental Science of Ukraine, Kyiv, 03041, Ukraine
| | - Igor Vareniuk
- Department of Biophysics and Medical Informatics, ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, Kyiv, 01601, Ukraine
| | - Kateryna Bogutska
- Department of Biophysics and Medical Informatics, ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, Kyiv, 01601, Ukraine
| | - Serhii Braniuk
- Faculty of Biology and Forestry, Lesya Ukrainka Volyn National University, Lutsk, 43025, Ukraine
| | - Olexandr Korotkyi
- Department of Biophysics and Medical Informatics, ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, Kyiv, 01601, Ukraine
| | - Yuriy Prylutskyy
- Department of Biophysics and Medical Informatics, ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, Kyiv, 01601, Ukraine
| | - Uwe Ritter
- Institute of Chemistry and Biotechnology, Technical University of Ilmenau, Ilmenau, 98693, Germany
| | - Jacek Piosik
- Intercollegiate Faculty of Biotechnology, University of Gdansk, 80-307, Gdańsk, Poland
| |
Collapse
|
7
|
Zavodovskiy DO, Bulgakova NV, Sokolowska I, Prylutskyy YI, Ritter U, Gonchar OO, Kostyukov AI, Vlasenko OV, Butowska K, Borowik A, Piosik J, Maznychenko A. Water-soluble pristine C 60 fullerenes attenuate isometric muscle force reduction in a rat acute inflammatory pain model. BMC Musculoskelet Disord 2023; 24:606. [PMID: 37491190 PMCID: PMC10367279 DOI: 10.1186/s12891-023-06719-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/12/2022] [Accepted: 07/14/2023] [Indexed: 07/27/2023] Open
Abstract
BACKGROUND Being a scavenger of free radicals, C60 fullerenes can influence on the physiological processes in skeletal muscles, however, the effect of such carbon nanoparticles on muscle contractility under acute muscle inflammation remains unclear. Thus, the aim of the study was to reveal the effect of the C60 fullerene aqueous solution (C60FAS) on the muscle contractile properties under acute inflammatory pain. METHODS To induce inflammation a 2.5% formalin solution was injected into the rat triceps surae (TS) muscle. High-frequency electrical stimulation has been used to induce tetanic muscle contraction. A linear motor under servo-control with embedded semi-conductor strain gauge resistors was used to measure the muscle tension. RESULTS In response to formalin administration, the strength of TS muscle contractions in untreated animals was recorded at 23% of control values, whereas the muscle tension in the C60FAS-treated rats reached 48%. Thus, the treated muscle could generate 2-fold more muscle strength than the muscle in untreated rats. CONCLUSIONS The attenuation of muscle contraction force reduction caused by preliminary injection of C60FAS is presumably associated with a decrease in the concentration of free radicals in the inflamed muscle tissue, which leads to a decrease in the intensity of nociceptive information transmission from the inflamed muscle to the CNS and thereby promotes the improvement of the functional state of the skeletal muscle.
Collapse
Affiliation(s)
| | | | - Inna Sokolowska
- Gdansk University of Physical Education and Sport, Kazimierza Gorskiego Str. 1, Gdansk 80- 336, Gdansk, Poland
| | - Yuriy I Prylutskyy
- ESC "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Volodymyrska Str. 64, Kyiv, 01601, Ukraine
| | - Uwe Ritter
- Institute of Chemistry and Biotechnology, Technical University of Ilmenau, Weimarer Str. 25, 98693, Ilmenau, Germany
| | - Olga O Gonchar
- Bogomoletz Institute of Physiology, Bogomoletz Str. 4, Kyiv, 01024, Ukraine
| | | | - Oleh V Vlasenko
- Laboratory of Experimental Neurophysiology, National Pirogov Memorial Medical University, Vinnytsya, Ukraine
| | - Kamila Butowska
- Laboratory of Biophysics, Intercollegiate Faculty of Biotechnology UG-MUG, Abrahama 58, Gdansk, 80-307, Poland
| | - Agnieszka Borowik
- Laboratory of Biophysics, Intercollegiate Faculty of Biotechnology UG-MUG, Abrahama 58, Gdansk, 80-307, Poland
| | - Jacek Piosik
- Laboratory of Biophysics, Intercollegiate Faculty of Biotechnology UG-MUG, Abrahama 58, Gdansk, 80-307, Poland.
| | - Andriy Maznychenko
- Bogomoletz Institute of Physiology, Bogomoletz Str. 4, Kyiv, 01024, Ukraine.
- Gdansk University of Physical Education and Sport, Kazimierza Gorskiego Str. 1, Gdansk 80- 336, Gdansk, Poland.
| |
Collapse
|
8
|
Ritter U. In situ veritas: combining omics and multiplex imaging can facilitate the detection and characterization of cell-cell interactions in tissues. Front Med (Lausanne) 2023; 10:1155057. [PMID: 37332762 PMCID: PMC10270289 DOI: 10.3389/fmed.2023.1155057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2023] [Accepted: 04/25/2023] [Indexed: 06/20/2023] Open
Affiliation(s)
- Uwe Ritter
- Chair for Immunology, University of Regensburg, Regensburg, Germany
- Department for Immunology, Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany
| |
Collapse
|
9
|
Grebinyk A, Prylutska S, Grebinyk S, Ponomarenko S, Virych P, Chumachenko V, Kutsevol N, Prylutskyy Y, Ritter U, Frohme M. Drug delivery with a pH-sensitive star-like dextran-graft polyacrylamide copolymer. Nanoscale Adv 2022; 4:5077-5088. [PMID: 36504750 PMCID: PMC9680934 DOI: 10.1039/d2na00353h] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 06/04/2022] [Accepted: 09/29/2022] [Indexed: 06/17/2023]
Abstract
The development of precision cancer medicine relies on novel formulation strategies for targeted drug delivery to increase the therapeutic outcome. Biocompatible polymer nanoparticles, namely dextran-graft-polyacrylamide (D-g-PAA) copolymers, represent one of the innovative non-invasive approaches for drug delivery applications in cancer therapy. In this study, the star-like D-g-PAA copolymer in anionic form (D-g-PAAan) was developed for pH-triggered targeted drug delivery of the common chemotherapeutic drugs - doxorubicin (Dox) and cisplatin (Cis). The initial D-g-PAA copolymer was synthesized by the radical graft polymerization method, and then alkaline-hydrolyzed to get this polymer in anionic form for further use for drug encapsulation. The acidification of the buffer promoted the release of loaded drugs. D-g-PAAan nanoparticles increased the toxic potential of the drugs against human and mouse lung carcinoma cells (A549 and LLC), but not against normal human lung cells (HEL299). The drug-loaded D-g-PAAan-nanoparticles promoted further oxidative stress and apoptosis induction in LLC cells. D-g-PAAan-nanoparticles improved Dox accumulation and drugs' toxicity in a 3D LLC multi-cellular spheroid model. The data obtained indicate that the strategy of chemotherapeutic drug encapsulation within the branched D-g-PAAan nanoparticle allows not only to realize pH-triggered drug release but also to potentiate its cytotoxic, prooxidant and proapoptotic effects against lung carcinoma cells.
Collapse
Affiliation(s)
- Anna Grebinyk
- Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau Hochschulring 1 15745 Wildau Germany
| | - Svitlana Prylutska
- National University of Life and Environmental Science of Ukraine Heroiv Oborony Str., 15 03041 Kyiv Ukraine
| | - Sergii Grebinyk
- Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau Hochschulring 1 15745 Wildau Germany
| | - Stanislav Ponomarenko
- Taras Shevchenko National University of Kyiv Volodymyrska Str., 64 01601 Kyiv Ukraine
| | - Pavlo Virych
- Taras Shevchenko National University of Kyiv Volodymyrska Str., 64 01601 Kyiv Ukraine
| | - Vasyl Chumachenko
- Taras Shevchenko National University of Kyiv Volodymyrska Str., 64 01601 Kyiv Ukraine
| | - Nataliya Kutsevol
- Taras Shevchenko National University of Kyiv Volodymyrska Str., 64 01601 Kyiv Ukraine
- Institute Charles Sadron 23 Rue du Loess 67200 Strasbourg France
| | - Yuriy Prylutskyy
- Taras Shevchenko National University of Kyiv Volodymyrska Str., 64 01601 Kyiv Ukraine
| | - Uwe Ritter
- Technical University of Ilmenau, Institute of Chemistry and Biotechnology Weimarer Str., 25 98693 Ilmenau Germany
| | - Marcus Frohme
- Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau Hochschulring 1 15745 Wildau Germany
| |
Collapse
|
10
|
Nerb B, Dudziak D, Gessner A, Feuerer M, Ritter U. Have We Ignored Vector-Associated Microbiota While Characterizing the Function of Langerhans Cells in Experimental Cutaneous Leishmaniasis? Front Trop Dis 2022. [DOI: 10.3389/fitd.2022.874081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
11
|
Nozdrenko D, Prylutska S, Bogutska K, Cherepanov V, Senenko A, Vygovska O, Khrapatyi S, Ritter U, Prylutskyy Y, Piosik J. Analysis of Biomechanical and Biochemical Markers of Rat Muscle Soleus Fatigue Processes Development during Long-Term Use of C60 Fullerene and N-Acetylcysteine. Nanomaterials 2022; 12:nano12091552. [PMID: 35564261 PMCID: PMC9105597 DOI: 10.3390/nano12091552] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/01/2022] [Revised: 04/29/2022] [Accepted: 04/29/2022] [Indexed: 12/02/2022]
Abstract
The development of an effective therapy aimed at restoring muscle dysfunctions in clinical and sports medicine, as well as optimizing working activity in general remains an urgent task today. Modern nanobiotechnologies are able to solve many clinical and social health problems, in particular, they offer new therapeutic approaches using biocompatible and bioavailable nanostructures with specific bioactivity. Therefore, the nanosized carbon molecule, C60 fullerene, as a powerful antioxidant, is very attractive. In this study, a comparative analysis of the dynamic of muscle soleus fatigue processes in rats was conducted using 50 Hz stimulation for 5 s with three consistent pools after intraperitoneal administration of the following antioxidants: C60 fullerene (a daily dose of 1 mg/kg one hour prior to the start of the experiment) and N-acetylcysteine (NAC; a daily dose of 150 mg/kg one hour prior to the start of the experiment) during five days. Changes in the integrated power of muscle contraction, levels of the maximum and minimum contraction force generation, time of reduction of the contraction force by 50% of its maximum value, achievement of the maximum force response, and delay of the beginning of a single contraction force response were analyzed as biomechanical markers of fatigue processes. Levels of creatinine, creatine phosphokinase, lactate, and lactate dehydrogenase, as well as pro- and antioxidant balance (thiobarbituric acid reactive substances, hydrogen peroxide, reduced glutathione, and catalase activity) in the blood of rats were analyzed as biochemical markers of fatigue processes. The obtained data indicate that applied therapeutic drugs have the most significant effects on the 2nd and especially the 3rd stimulation pools. Thus, the application of C60 fullerene has a (50–80)% stronger effect on the resumption of muscle biomechanics after the beginning of fatigue than NAC on the first day of the experiment. There is a clear trend toward a positive change in all studied biochemical parameters by about (12–15)% after therapeutic administration of NAC and by (20–25)% after using C60 fullerene throughout the experiment. These findings demonstrate the promise of using C60 fullerenes as potential therapeutic nanoagents that can reduce or adjust the pathological conditions of the muscular system that occur during fatigue processes in skeletal muscles.
Collapse
Affiliation(s)
- Dmytro Nozdrenko
- Department of Biophysics and Medical Informatics, ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, 01601 Kyiv, Ukraine; (D.N.); (K.B.)
| | - Svitlana Prylutska
- Department of Physiology, Plant Biochemistry and Bioenergetics, Faculty of Plant Protection, Biotechnology and Ecology, National University of Life and Environmental Science of Ukraine, 03041 Kyiv, Ukraine;
| | - Kateryna Bogutska
- Department of Biophysics and Medical Informatics, ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, 01601 Kyiv, Ukraine; (D.N.); (K.B.)
| | - Vsevolod Cherepanov
- Department of Physical Electronics, Institute of Physics, NAS of Ukraine, 03028 Kyiv, Ukraine; (V.C.); (A.S.)
| | - Anton Senenko
- Department of Physical Electronics, Institute of Physics, NAS of Ukraine, 03028 Kyiv, Ukraine; (V.C.); (A.S.)
| | - Oksana Vygovska
- Department of Pediatric Infectious Diseases, Bogomolets National Medical University of Kyiv, 01601 Kyiv, Ukraine;
| | - Sergii Khrapatyi
- Department of Computational Mathematics and Computer Modeling, Interregional Academy of Personnel Management, 03039 Kyiv, Ukraine;
| | - Uwe Ritter
- Institute of Chemistry and Biotechnology, Technical University of Ilmenau, 98693 Ilmenau, Germany;
| | - Yuriy Prylutskyy
- Department of Biophysics and Medical Informatics, ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, 01601 Kyiv, Ukraine; (D.N.); (K.B.)
- Correspondence: (Y.P.); (J.P.)
| | - Jacek Piosik
- Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, 80-307 Gdansk, Poland
- Correspondence: (Y.P.); (J.P.)
| |
Collapse
|
12
|
Al Kury LT, Papandreou D, Hurmach VV, Dryn DO, Melnyk MI, Platonov MO, Prylutskyy YI, Ritter U, Scharff P, Zholos AV. Single-Walled Carbon Nanotubes Inhibit TRPC4-Mediated Muscarinic Cation Current in Mouse Ileal Myocytes. Nanomaterials (Basel) 2021; 11:nano11123410. [PMID: 34947764 PMCID: PMC8703819 DOI: 10.3390/nano11123410] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/21/2021] [Revised: 12/10/2021] [Accepted: 12/13/2021] [Indexed: 12/02/2022]
Abstract
Single-walled carbon nanotubes (SWCNTs) are characterized by a combination of rather unique physical and chemical properties, which makes them interesting biocompatible nanostructured materials for various applications, including in the biomedical field. SWCNTs are not inert carriers of drug molecules, as they may interact with various biological macromolecules, including ion channels. To investigate the mechanisms of the inhibitory effects of SWCNTs on the muscarinic receptor cation current (mICAT), induced by intracellular GTPγs (200 μM), in isolated mouse ileal myocytes, we have used the patch-clamp method in the whole-cell configuration. Here, we use molecular docking/molecular dynamics simulations and direct patch-clamp recordings of whole-cell currents to show that SWCNTs, purified and functionalized by carboxylation in water suspension containing single SWCNTs with a diameter of 0.5–1.5 nm, can inhibit mICAT, which is mainly carried by TRPC4 cation channels in ileal smooth muscle cells, and is the main regulator of cholinergic excitation–contraction coupling in the small intestinal tract. This inhibition was voltage-independent and associated with a shortening of the mean open time of the channel. These results suggest that SWCNTs cause a direct blockage of the TRPC4 channel and may represent a novel class of TRPC4 modulators.
Collapse
Affiliation(s)
- Lina T. Al Kury
- College of Natural and Health Sciences, Zayed University, Abu Dhabi 144534, United Arab Emirates; (L.T.A.K.); (D.P.)
| | - Dimitrios Papandreou
- College of Natural and Health Sciences, Zayed University, Abu Dhabi 144534, United Arab Emirates; (L.T.A.K.); (D.P.)
| | - Vasyl V. Hurmach
- ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, 64 Volodymyrska Str., 01601 Kyiv, Ukraine; (V.V.H.); (D.O.D.); (M.I.M.); (Y.I.P.)
| | - Dariia O. Dryn
- ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, 64 Volodymyrska Str., 01601 Kyiv, Ukraine; (V.V.H.); (D.O.D.); (M.I.M.); (Y.I.P.)
- O.O. Bogomoletz Institute of Physiology, National Academy of Sciences of Ukraine, 4 Bogomoletz Str., 01024 Kyiv, Ukraine
- Institute of Pharmacology and Toxicology, National Academy of Medical Sciences of Ukraine, 14 Anton Tsedik Str., 03057 Kyiv, Ukraine
| | - Mariia I. Melnyk
- ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, 64 Volodymyrska Str., 01601 Kyiv, Ukraine; (V.V.H.); (D.O.D.); (M.I.M.); (Y.I.P.)
- O.O. Bogomoletz Institute of Physiology, National Academy of Sciences of Ukraine, 4 Bogomoletz Str., 01024 Kyiv, Ukraine
- Institute of Pharmacology and Toxicology, National Academy of Medical Sciences of Ukraine, 14 Anton Tsedik Str., 03057 Kyiv, Ukraine
| | - Maxim O. Platonov
- Institute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine, 150 Zabolotnogo Str., 03143 Kyiv, Ukraine;
| | - Yuriy I. Prylutskyy
- ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, 64 Volodymyrska Str., 01601 Kyiv, Ukraine; (V.V.H.); (D.O.D.); (M.I.M.); (Y.I.P.)
| | - Uwe Ritter
- Institute of Chemistry and Biotechnology, Technical University of Ilmenau, 25 Weimarer Str., 98693 Ilmenau, Germany; (U.R.); (P.S.)
| | - Peter Scharff
- Institute of Chemistry and Biotechnology, Technical University of Ilmenau, 25 Weimarer Str., 98693 Ilmenau, Germany; (U.R.); (P.S.)
| | - Alexander V. Zholos
- ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, 64 Volodymyrska Str., 01601 Kyiv, Ukraine; (V.V.H.); (D.O.D.); (M.I.M.); (Y.I.P.)
- Correspondence: ; Tel.: +380-44-4312-0403
| |
Collapse
|
13
|
Horak I, Prylutska S, Krysiuk I, Luhovskyi S, Hrabovsky O, Tverdokhleb N, Franskevych D, Rumiantsev D, Senenko A, Evstigneev M, Drobot L, Matyshevska O, Ritter U, Piosik J, Prylutskyy Y. Nanocomplex of Berberine with C 60 Fullerene Is a Potent Suppressor of Lewis Lung Carcinoma Cells Invasion In Vitro and Metastatic Activity In Vivo. Materials (Basel) 2021; 14:ma14206114. [PMID: 34683705 PMCID: PMC8540026 DOI: 10.3390/ma14206114] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/06/2021] [Revised: 10/01/2021] [Accepted: 10/08/2021] [Indexed: 12/12/2022]
Abstract
Effective targeting of metastasis is considered the main problem in cancer therapy. The development of herbal alkaloid Berberine (Ber)-based anticancer drugs is limited due to Ber’ low effective concentration, poor membrane permeability, and short plasma half-life. To overcome these limitations, we used Ber noncovalently bound to C60 fullerene (C60). The complexation between C60 and Ber molecules was evidenced with computer simulation. The aim of the present study was to estimate the effect of the free Ber and C60-Ber nanocomplex in a low Ber equivalent concentration on Lewis lung carcinoma cells (LLC) invasion potential, expression of epithelial-to-mesenchymal transition (EMT) markers in vitro, and the ability of cancer cells to form distant lung metastases in vivo in a mice model of LLC. It was shown that in contrast to free Ber its nanocomplex with C60 demonstrated significantly higher efficiency to suppress invasion potential, to downregulate the level of EMT-inducing transcription factors SNAI1, ZEB1, and TWIST1, to unblock expression of epithelial marker E-cadherin, and to repress cancer stem cells-like markers. More importantly, a relatively low dose of C60-Ber nanocomplex was able to suppress lung metastasis in vivo. These findings indicated that сomplexation of natural alkaloid Ber with C60 can be used as an additional therapeutic strategy against aggressive lung cancer.
Collapse
Affiliation(s)
- Iryna Horak
- Palladin Institute of Biochemistry, NAS of Ukraine, 9 Leontovicha Str., 01030 Kyiv, Ukraine; (I.H.); (I.K.); (O.H.); (L.D.); (O.M.)
| | - Svitlana Prylutska
- Faculty of Plant Ptotection, Biotechnology and Ecology, National University of Life and Environmental Science of Ukraine, 15 Heroiv Oborony Str., 03041 Kyiv, Ukraine
- Correspondence: (S.P.); (J.P.)
| | - Iryna Krysiuk
- Palladin Institute of Biochemistry, NAS of Ukraine, 9 Leontovicha Str., 01030 Kyiv, Ukraine; (I.H.); (I.K.); (O.H.); (L.D.); (O.M.)
| | - Serhii Luhovskyi
- Chebotarov Institute of Gerontology, NAS of Ukraine, 67 Vyshgorodska Str., 04114 Kyiv, Ukraine;
| | - Oleksii Hrabovsky
- Palladin Institute of Biochemistry, NAS of Ukraine, 9 Leontovicha Str., 01030 Kyiv, Ukraine; (I.H.); (I.K.); (O.H.); (L.D.); (O.M.)
| | - Nina Tverdokhleb
- Leibniz Institute of Polymer Research Dresden, 6 Hohe Str., 01069 Dresden, Germany;
| | - Daria Franskevych
- Department of Biophysics and Medical Informatics, Taras Shevchenko National University of Kyiv, 64 Volodymyrska Str., 01601 Kyiv, Ukraine; (D.F.); (Y.P.)
| | - Dmytro Rumiantsev
- Institute of Physics, NAS of Ukraine, 46 Nauky Ave., 03028 Kyiv, Ukraine; (D.R.); (A.S.)
| | - Anton Senenko
- Institute of Physics, NAS of Ukraine, 46 Nauky Ave., 03028 Kyiv, Ukraine; (D.R.); (A.S.)
| | - Maxim Evstigneev
- Department of Biology and Chemistry, Belgorod State University, 85 Pobedy Str., 308015 Belgorod, Russia;
| | - Liudmyla Drobot
- Palladin Institute of Biochemistry, NAS of Ukraine, 9 Leontovicha Str., 01030 Kyiv, Ukraine; (I.H.); (I.K.); (O.H.); (L.D.); (O.M.)
| | - Olga Matyshevska
- Palladin Institute of Biochemistry, NAS of Ukraine, 9 Leontovicha Str., 01030 Kyiv, Ukraine; (I.H.); (I.K.); (O.H.); (L.D.); (O.M.)
| | - Uwe Ritter
- Institute of Chemistry and Biotechnology, Technical University of Ilmenau, 25 Weimarer Str., 98693 Ilmenau, Germany;
| | - Jacek Piosik
- Intercollegiate Faculty of Biotechnology, UG-MUG (University of Gdansk and Medical University of Gdansk), Abrahama 58, 80-307 Gdańsk, Poland
- Correspondence: (S.P.); (J.P.)
| | - Yuriy Prylutskyy
- Department of Biophysics and Medical Informatics, Taras Shevchenko National University of Kyiv, 64 Volodymyrska Str., 01601 Kyiv, Ukraine; (D.F.); (Y.P.)
| |
Collapse
|
14
|
Hurmach VV, Platonov MO, Prylutska SV, Scharff P, Prylutskyy YI, Ritter U. C 60 fullerene against SARS-CoV-2 coronavirus: an in silico insight. Sci Rep 2021; 11:17748. [PMID: 34493768 PMCID: PMC8423725 DOI: 10.1038/s41598-021-97268-6] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2021] [Accepted: 08/24/2021] [Indexed: 01/18/2023] Open
Abstract
Based on WHO reports the new SARS-CoV-2 coronavirus is currently widespread all over the world. So far > 162 million cases have been confirmed, including > 3 million deaths. Because of the pandemic still spreading across the globe the accomplishment of computational methods to find new potential mechanisms of virus inhibitions is necessary. According to the fact that C60 fullerene (a sphere-shaped molecule consisting of carbon) has shown inhibitory activity against various protein targets, here the analysis of the potential binding mechanism between SARS-CoV-2 proteins 3CLpro and RdRp with C60 fullerene was done; it has resulted in one and two possible binding mechanisms, respectively. In the case of 3CLpro, C60 fullerene interacts in the catalytic binding pocket. And for RdRp in the first model C60 fullerene blocks RNA synthesis pore and in the second one it prevents binding with Nsp8 co-factor (without this complex formation, RdRp can't perform its initial functions). Then the molecular dynamics simulation confirmed the stability of created complexes. The obtained results might be a basis for other computational studies of 3CLPro and RdRp potential inhibition ways as well as the potential usage of C60 fullerene in the fight against COVID-19 disease.
Collapse
Affiliation(s)
- Vasyl V Hurmach
- Taras Shevchenko National University of Kyiv, Kyiv, 01601, Ukraine
| | - Maksim O Platonov
- Institute of Molecular Biology and Genetics of NASU, Kyiv, 03143, Ukraine
| | - Svitlana V Prylutska
- Taras Shevchenko National University of Kyiv, Kyiv, 01601, Ukraine
- National University of Life and Environmental Science of Ukraine, Kyiv, 03041, Ukraine
| | - Peter Scharff
- Institute of Chemistry and Biotechnology, Technical University of Ilmenau, 98693, Ilmenau, Germany
| | | | - Uwe Ritter
- Institute of Chemistry and Biotechnology, Technical University of Ilmenau, 98693, Ilmenau, Germany.
| |
Collapse
|
15
|
Grebinyk A, Prylutska S, Grebinyk S, Evstigneev M, Krysiuk I, Skaterna T, Horak I, Sun Y, Drobot L, Matyshevska O, Prylutskyy Y, Ritter U, Frohme M. Antitumor efficiency of the natural alkaloid berberine complexed with C60 fullerene in Lewis lung carcinoma in vitro and in vivo. Cancer Nanotechnol 2021. [DOI: 10.1186/s12645-021-00096-6] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
Abstract
Background
Berberine (Ber) is a herbal alkaloid with pharmacological activity in general and a high anticancer potency in particular. However, due to its low bioavailability, the difficulty in reaching a target and choosing the right dose, there is a need to improve approaches of Ber use in anticancer therapy. In this study, Ber, noncovalently bound to a carbon nanostructure C60 fullerene (C60) at various molar ratios of the components, was explored against Lewis lung carcinoma (LLC).
Methods
C60–Ber noncovalent nanocomplexes were synthesized in 1:2, 1:1 and 2:1 molar ratios. Ber release from the nanocomplexes was studied after prolonged incubation at different pH with the liquid chromatography–mass spectrometry analysis of free Ber content. Biological effects of the free and C60-complaxated Ber were studied in vitro towards LLC cells with phase-contrast and fluorescence microscopy, flow cytometry, MTT reduction, caspase activity and wound closure assays. The treatment with C60–Ber nanocomplex was evaluated in vivo with the LLC-tumored C57Bl mice. The mice body weight, tumor size, tumor weight and tumor weight index were assessed for four groups, treated with saline, 15 mg C60/kg, 7.5 mg Ber/kg or 2:1 C60-Ber nanocomplex (15 mg C60/kg, 7.5 mg Ber/kg).
Results
Ber release from C60–Ber nanocomplexes was promoted with medium acidification. LLC cells treatment with C60–Ber nanocomplexes was followed by enhanced Ber intracellular uptake as compared to free Ber. The cytotoxicity of the studied agents followed the order: free Ber < 1:2 < 1:1 < 2:1 C60–Ber nanocomplex. The potency of cytotoxic effect of 2:1 C60–Ber nanocomplex was confirmed by 21.3-fold decrease of IC50 value (0.8 ± 0.3 µM) compared to IC50 for free Ber (17 ± 2 µM). C60–Ber nanocomplexes induced caspase 3/7 activation and suppressed the migration activity of LLC cells. The therapeutic potency of 2:1 C60–Ber nanocomplex was confirmed in a mouse model of LLC. The tumor growth in the group treated with 2:1 C60–Ber nanocomplex is suppressed by approximately 50% at the end of experiment, while in the tumor-bearing group treated with free Ber no therapeutic effect was detected.
Conclusions
This study indicates that complexation of natural alkaloid Ber with C60 may be a novel therapeutic strategy against lung carcinoma.
Graphical abstract
Collapse
|
16
|
Chanyalew M, Abebe M, Endale B, Girma S, Tasew G, Bobosha K, Zewide M, Howe R, van Zandbergen G, Ritter U, Gadisa E, Aseffa A, Laskay T. Enhanced activation of blood neutrophils and monocytes in patients with Ethiopian localized cutaneous leishmaniasis in response to Leishmania aethiopica Neutrophil activation in Ethiopian cutaneous leishmaniasis. Acta Trop 2021; 220:105967. [PMID: 34029532 DOI: 10.1016/j.actatropica.2021.105967] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2020] [Revised: 05/04/2021] [Accepted: 05/16/2021] [Indexed: 11/15/2022]
Abstract
Recent studies suggest an essential role of the innate immune effector cells neutrophils and monocytes in protection or disease progression in the early course of Leishmania infection. In areas endemic for cutaneous leishmaniasis in Ethiopia most individuals are exposed to bites of infected sandflies. Still only a minor ratio of the inhabitants develops symptomatic disease. Neutrophils, followed by monocytes, are the first cells to be recruited to the site of Leishmania infection, the initial response of neutrophils to parasites appears to be crucial for the protective response and disease outcome. Our working hypothesis is that neutrophils and/or monocytes in localized cutaneous leishmaniasis (LCL) patients may have defects in function of innate immune cell that contribute to failure to parasite clearance that lead to establishment of infection. The response of cells in Ethiopian LCL patients and healthy controls to Leishmania aethiopica and to the Toll like receptor (TLR) agonists lipopolysaccharide (LPS) and macrophage activating lipopeptide-2 (MALP-2) was investigated by assessing the cell surface expression of CD62L (on neutrophil and monocyte) and CD66b (only on neutrophil), as well as reactive oxygen species (ROS) production by using whole blood-based assays in vitro. No impaired response of neutrophils and monocytes to the microbial constituents LPS and MALP-2 was observed. Neutrophils and monocytes from LCL patients responded stronger to Leishmania aethiopica in the applied whole blood assays than cells from healthy individuals. These experimental findings do not support the hypothesis regarding a possible dysfunction of neutrophils and monocytes in cutaneous leishmaniasis. On the contrary, these cells react stronger in LCL patients as compared to healthy controls. The differential response to L. aethiopica observed between LCL patients and healthy controls have the potential to serve as biomarker to develop FACS based diagnostic/ prognostic techniques for LCL.
Collapse
Affiliation(s)
- Menberework Chanyalew
- Research and Innovation Division, Armauer Hansen Research Institute, P.O. Box 1005, Addis Ababa, Ethiopia.
| | - Markos Abebe
- Research and Innovation Division, Armauer Hansen Research Institute, P.O. Box 1005, Addis Ababa, Ethiopia
| | - Birtukan Endale
- Research and Innovation Division, Armauer Hansen Research Institute, P.O. Box 1005, Addis Ababa, Ethiopia
| | - Selfu Girma
- Research and Innovation Division, Armauer Hansen Research Institute, P.O. Box 1005, Addis Ababa, Ethiopia
| | - Geremew Tasew
- Research and Innovation Division, Armauer Hansen Research Institute, P.O. Box 1005, Addis Ababa, Ethiopia; Leishmaniasis Research Laboratory, Ethiopian Public Health Institute, P.O. Box 1242, Addis Ababa, Ethiopia
| | - Kidist Bobosha
- Research and Innovation Division, Armauer Hansen Research Institute, P.O. Box 1005, Addis Ababa, Ethiopia
| | - Martha Zewide
- Research and Innovation Division, Armauer Hansen Research Institute, P.O. Box 1005, Addis Ababa, Ethiopia.
| | - Rawleigh Howe
- Research and Innovation Division, Armauer Hansen Research Institute, P.O. Box 1005, Addis Ababa, Ethiopia
| | - Ger van Zandbergen
- Division of Immunology, Paul-Ehrlich-Institute, Federal Institute for Vaccines and Biomedicines, Langen D-63225, Germany.
| | - Uwe Ritter
- Regensburg Center for Interventional Immunology (RCI), Institute of Immunology, University Medical Center Regensburg, University of Regensburg, Regensburg D-93053, Germany.
| | - Endalamaw Gadisa
- Research and Innovation Division, Armauer Hansen Research Institute, P.O. Box 1005, Addis Ababa, Ethiopia
| | - Abraham Aseffa
- Research and Innovation Division, Armauer Hansen Research Institute, P.O. Box 1005, Addis Ababa, Ethiopia
| | - Tamás Laskay
- Department of Infectious Diseases and Microbiology, University of Lübeck, Lübeck D-23560, Germany.
| |
Collapse
|
17
|
Chernykh M, Zavalny D, Sokolova V, Ponomarenko S, Prylutska S, Kuziv Y, Chumachenko V, Marynin A, Kutsevol N, Epple M, Ritter U, Piosik J, Prylutskyy Y. A New Water-Soluble Thermosensitive Star-Like Copolymer as a Promising Carrier of the Chemotherapeutic Drug Doxorubicin. Materials (Basel) 2021; 14:ma14133517. [PMID: 34202610 PMCID: PMC8269508 DOI: 10.3390/ma14133517] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/18/2021] [Revised: 06/11/2021] [Accepted: 06/21/2021] [Indexed: 11/19/2022]
Abstract
A new water-soluble thermosensitive star-like copolymer, dextran-graft-poly-N-iso-propilacrylamide (D-g-PNIPAM), was created and characterized by various techniques (size-exclusion chromatography, differential scanning calorimetry, Fourier-transform infrared (FTIR) spectroscopy, and dynamic light scattering (DLS) spectroscopy). The viability of cancer cell lines (human transformed cervix epithelial cells, HeLa) as a model for cancer cells was studied using MTT and Live/Dead assays after incubation with a D-g-PNIPAM copolymer as a carrier for the drug doxorubicin (Dox) as well as a D-g-PNIPAM + Dox mixture as a function of the concentration. FTIR spectroscopy clearly indicated the complex formation of Dox with the D-g-PNIPAM copolymer. The size distribution of particles in Hank’s solution was determined by the DLS technique at different temperatures. The in vitro uptake of the studied D-g-PNIPAM + Dox nanoparticles into cancer cells was demonstrated by confocal laser scanning microscopy. It was found that D-g-PNIPAM + Dox nanoparticles in contrast to Dox alone showed higher toxicity toward cancer cells. All of the aforementioned facts indicate a possibility of further preclinical studies of the water-soluble D-g-PNIPAM particles’ behavior in animal tumor models in vivo as promising carriers of anticancer agents.
Collapse
Affiliation(s)
- Mariia Chernykh
- Taras Shevchenko National University of Kyiv, Volodymyrska Street, 64, 01601 Kyiv, Ukraine; (M.C.); (D.Z.); (S.P.); (Y.K.); (V.C.); (N.K.)
| | - Dmytro Zavalny
- Taras Shevchenko National University of Kyiv, Volodymyrska Street, 64, 01601 Kyiv, Ukraine; (M.C.); (D.Z.); (S.P.); (Y.K.); (V.C.); (N.K.)
| | - Viktoriya Sokolova
- Center for Nanointegration Duisburg-Essen (CeNIDE), Institute of Inorganic Chemistry, University of Duisburg-Essen, University Street, 5-7, 45117 Essen, Germany; (V.S.); (M.E.)
| | - Stanislav Ponomarenko
- Taras Shevchenko National University of Kyiv, Volodymyrska Street, 64, 01601 Kyiv, Ukraine; (M.C.); (D.Z.); (S.P.); (Y.K.); (V.C.); (N.K.)
| | - Svitlana Prylutska
- Department of Physiology, Plant Biochemistry and Bioenergetics, National University of Life and Environmental Science of Ukraine, Heroiv Oborony Street, 15, 03041 Kyiv, Ukraine;
| | - Yuliia Kuziv
- Taras Shevchenko National University of Kyiv, Volodymyrska Street, 64, 01601 Kyiv, Ukraine; (M.C.); (D.Z.); (S.P.); (Y.K.); (V.C.); (N.K.)
| | - Vasyl Chumachenko
- Taras Shevchenko National University of Kyiv, Volodymyrska Street, 64, 01601 Kyiv, Ukraine; (M.C.); (D.Z.); (S.P.); (Y.K.); (V.C.); (N.K.)
| | - Andrii Marynin
- National University of Food Technologies of Ukraine, Volodymyrska Street, 01033 Kyiv, Ukraine;
| | - Nataliya Kutsevol
- Taras Shevchenko National University of Kyiv, Volodymyrska Street, 64, 01601 Kyiv, Ukraine; (M.C.); (D.Z.); (S.P.); (Y.K.); (V.C.); (N.K.)
| | - Matthias Epple
- Center for Nanointegration Duisburg-Essen (CeNIDE), Institute of Inorganic Chemistry, University of Duisburg-Essen, University Street, 5-7, 45117 Essen, Germany; (V.S.); (M.E.)
| | - Uwe Ritter
- Institute of Chemistry and Biotechnology, Technical University of Ilmenau, Weimarer Street, 25, 98693 Ilmenau, Germany;
| | - Jacek Piosik
- Laboratory of Biophysics, Intercollegiate Faculty of Biotechnology UG-MUG, University of Gdansk, Abrahama 58, 80-307 Gdańsk, Poland
- Correspondence: (J.P.); (Y.P.)
| | - Yuriy Prylutskyy
- Taras Shevchenko National University of Kyiv, Volodymyrska Street, 64, 01601 Kyiv, Ukraine; (M.C.); (D.Z.); (S.P.); (Y.K.); (V.C.); (N.K.)
- Correspondence: (J.P.); (Y.P.)
| |
Collapse
|
18
|
Nozdrenko D, Abramchuk O, Prylutska S, Vygovska O, Soroca V, Bogutska K, Khrapatyi S, Prylutskyy Y, Scharff P, Ritter U. Analysis of Biomechanical Parameters of Muscle Soleus Contraction and Blood Biochemical Parameters in Rat with Chronic Glyphosate Intoxication and Therapeutic Use of C 60 Fullerene. Int J Mol Sci 2021; 22:4977. [PMID: 34067082 PMCID: PMC8124638 DOI: 10.3390/ijms22094977] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2021] [Revised: 04/26/2021] [Accepted: 05/05/2021] [Indexed: 01/08/2023] Open
Abstract
The widespread use of glyphosate as a herbicide in agriculture can lead to the presence of its residues and metabolites in food for human consumption and thus pose a threat to human health. It has been found that glyphosate reduces energy metabolism in the brain, its amount increases in white muscle fibers. At the same time, the effect of chronic use of glyphosate on the dynamic properties of skeletal muscles remains practically unexplored. The selected biomechanical parameters (the integrated power of muscle contraction, the time of reaching the muscle contraction force its maximum value and the reduction of the force response by 50% and 25% of the initial values during stimulation) of muscle soleus contraction in rats, as well as blood biochemical parameters (the levels of creatinine, creatine phosphokinase, lactate, lactate dehydrogenase, thiobarbituric acid reactive substances, hydrogen peroxide, reduced glutathione and catalase) were analyzed after chronic glyphosate intoxication (oral administration at a dose of 10 μg/kg of animal weight) for 30 days. Water-soluble C60 fullerene, as a poweful antioxidant, was used as a therapeutic nanoagent throughout the entire period of intoxication with the above herbicide (oral administration at doses of 0.5 or 1 mg/kg). The data obtained show that the introduction of C60 fullerene at a dose of 0.5 mg/kg reduces the degree of pathological changes by 40-45%. Increasing the dose of C60 fullerene to 1 mg/kg increases the therapeutic effect by 55-65%, normalizing the studied biomechanical and biochemical parameters. Thus, C60 fullerenes can be effective nanotherapeutics in the treatment of glyphosate-based herbicide poisoning.
Collapse
Affiliation(s)
- Dmytro Nozdrenko
- Department of Biophysics and Medical Informatic, Taras Shevchenko National University of Kyiv, 01601 Kyiv, Ukraine; (D.N.); (S.P.); (V.S.); (K.B.); (Y.P.)
| | - Olga Abramchuk
- Lesya Ukrainka Volyn National University, 43025 Lutsk, Ukraine;
| | - Svitlana Prylutska
- Department of Biophysics and Medical Informatic, Taras Shevchenko National University of Kyiv, 01601 Kyiv, Ukraine; (D.N.); (S.P.); (V.S.); (K.B.); (Y.P.)
- National University of Life and Environmental Science of Ukraine, 03041 Kyiv, Ukraine
| | - Oksana Vygovska
- Bogomolets National Medical University of Kyiv, 01601 Kyiv, Ukraine;
| | - Vasil Soroca
- Department of Biophysics and Medical Informatic, Taras Shevchenko National University of Kyiv, 01601 Kyiv, Ukraine; (D.N.); (S.P.); (V.S.); (K.B.); (Y.P.)
| | - Kateryna Bogutska
- Department of Biophysics and Medical Informatic, Taras Shevchenko National University of Kyiv, 01601 Kyiv, Ukraine; (D.N.); (S.P.); (V.S.); (K.B.); (Y.P.)
| | - Sergii Khrapatyi
- Interregional Academy of Personnel Management, 03039 Kyiv, Ukraine;
| | - Yuriy Prylutskyy
- Department of Biophysics and Medical Informatic, Taras Shevchenko National University of Kyiv, 01601 Kyiv, Ukraine; (D.N.); (S.P.); (V.S.); (K.B.); (Y.P.)
| | - Peter Scharff
- Institute of Chemistry and Biotechnology, Technical University of Ilmenau, 98693 Ilmenau, Germany;
| | - Uwe Ritter
- Institute of Chemistry and Biotechnology, Technical University of Ilmenau, 98693 Ilmenau, Germany;
| |
Collapse
|
19
|
Delacher M, Simon M, Sanderink L, Hotz-Wagenblatt A, Wuttke M, Schambeck K, Schmidleithner L, Bittner S, Pant A, Ritter U, Hehlgans T, Riegel D, Schneider V, Groeber-Becker FK, Eigenberger A, Gebhard C, Strieder N, Fischer A, Rehli M, Hoffmann P, Edinger M, Strowig T, Huehn J, Schmidl C, Werner JM, Prantl L, Brors B, Imbusch CD, Feuerer M. Single-cell chromatin accessibility landscape identifies tissue repair program in human regulatory T cells. Immunity 2021; 54:702-720.e17. [PMID: 33789089 PMCID: PMC8050210 DOI: 10.1016/j.immuni.2021.03.007] [Citation(s) in RCA: 66] [Impact Index Per Article: 22.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2020] [Revised: 10/05/2020] [Accepted: 03/10/2021] [Indexed: 02/07/2023]
Abstract
Murine regulatory T (Treg) cells in tissues promote tissue homeostasis and regeneration. We sought to identify features that characterize human Treg cells with these functions in healthy tissues. Single-cell chromatin accessibility profiles of murine and human tissue Treg cells defined a conserved, microbiota-independent tissue-repair Treg signature with a prevailing footprint of the transcription factor BATF. This signature, combined with gene expression profiling and TCR fate mapping, identified a population of tissue-like Treg cells in human peripheral blood that expressed BATF, chemokine receptor CCR8 and HLA-DR. Human BATF+CCR8+ Treg cells from normal skin and adipose tissue shared features with nonlymphoid T follicular helper-like (Tfh-like) cells, and induction of a Tfh-like differentiation program in naive human Treg cells partially recapitulated tissue Treg regenerative characteristics, including wound healing potential. Human BATF+CCR8+ Treg cells from healthy tissue share features with tumor-resident Treg cells, highlighting the importance of understanding the context-specific functions of these cells.
Collapse
Affiliation(s)
- Michael Delacher
- Regensburg Center for Interventional Immunology (RCI); Chair for Immunology, University Regensburg, 93053 Regensburg, Germany; Institute of Immunology, University Medical Center Mainz, 55131 Mainz, Germany; Research Centre for Immunotherapy, University Medical Center Mainz, 55131 Mainz, Germany
| | - Malte Simon
- Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
| | - Lieke Sanderink
- Regensburg Center for Interventional Immunology (RCI); Chair for Immunology, University Regensburg, 93053 Regensburg, Germany
| | - Agnes Hotz-Wagenblatt
- Core Facility Omics IT and Data management (ODCF), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
| | - Marina Wuttke
- Regensburg Center for Interventional Immunology (RCI); Chair for Immunology, University Regensburg, 93053 Regensburg, Germany
| | - Kathrin Schambeck
- Regensburg Center for Interventional Immunology (RCI); Chair for Immunology, University Regensburg, 93053 Regensburg, Germany
| | - Lisa Schmidleithner
- Regensburg Center for Interventional Immunology (RCI); Chair for Immunology, University Regensburg, 93053 Regensburg, Germany
| | - Sebastian Bittner
- Regensburg Center for Interventional Immunology (RCI); Chair for Immunology, University Regensburg, 93053 Regensburg, Germany
| | - Asmita Pant
- Regensburg Center for Interventional Immunology (RCI); Chair for Immunology, University Regensburg, 93053 Regensburg, Germany
| | - Uwe Ritter
- Regensburg Center for Interventional Immunology (RCI); Chair for Immunology, University Regensburg, 93053 Regensburg, Germany
| | - Thomas Hehlgans
- Regensburg Center for Interventional Immunology (RCI); Chair for Immunology, University Regensburg, 93053 Regensburg, Germany
| | - Dania Riegel
- Regensburg Center for Interventional Immunology (RCI)
| | - Verena Schneider
- University Hospital Würzburg, Department of Tissue Engineering and Regenerative Medicine TERM, 97070 Würzburg, Germany; Fraunhofer Institute for Silicate Research ISC, Translational Center for Regenerative Therapies TLZ-RT, 97082 Würzburg, Germany
| | - Florian Kai Groeber-Becker
- University Hospital Würzburg, Department of Tissue Engineering and Regenerative Medicine TERM, 97070 Würzburg, Germany; Fraunhofer Institute for Silicate Research ISC, Translational Center for Regenerative Therapies TLZ-RT, 97082 Würzburg, Germany
| | - Andreas Eigenberger
- Department of Plastic, Hand- and Reconstructive Surgery, University Hospital Regensburg, 93053 Regensburg, Germany
| | | | | | - Alexander Fischer
- Regensburg Center for Interventional Immunology (RCI); Department of Internal Medicine III, University Hospital Regensburg, 93053 Regensburg, Germany
| | - Michael Rehli
- Regensburg Center for Interventional Immunology (RCI); Department of Internal Medicine III, University Hospital Regensburg, 93053 Regensburg, Germany
| | - Petra Hoffmann
- Regensburg Center for Interventional Immunology (RCI); Department of Internal Medicine III, University Hospital Regensburg, 93053 Regensburg, Germany
| | - Matthias Edinger
- Regensburg Center for Interventional Immunology (RCI); Department of Internal Medicine III, University Hospital Regensburg, 93053 Regensburg, Germany
| | - Till Strowig
- Department of Microbial Immune Regulation, Helmholtz Centre for Infection Research, 38124 Braunschweig, Germany; Hannover Medical School, 30625 Hannover, Germany; RESIST, Cluster of Excellence 2155, Hannover Medical School, 30625 Hannover, Germany
| | - Jochen Huehn
- Department of Experimental Immunology, Helmholtz Centre for Infection Research, 38124 Braunschweig, Germany; RESIST, Cluster of Excellence 2155, Hannover Medical School, 30625 Hannover, Germany
| | | | - Jens M Werner
- Department of Surgery, University Hospital Regensburg, 93053 Regensburg, Germany
| | - Lukas Prantl
- Department of Plastic, Hand- and Reconstructive Surgery, University Hospital Regensburg, 93053 Regensburg, Germany
| | - Benedikt Brors
- Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
| | - Charles D Imbusch
- Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
| | - Markus Feuerer
- Regensburg Center for Interventional Immunology (RCI); Chair for Immunology, University Regensburg, 93053 Regensburg, Germany.
| |
Collapse
|
20
|
Strutynska N, Livitska O, Prylutska S, Yumyna Y, Zelena P, Skivka L, Malyshenko A, Vovchenko L, Strelchuk V, Prylutskyy Y, Slobodyanik N, Ritter U. New nanostructured apatite-type (Na+,Zn2+,CO32−)-doped calcium phosphates: Preparation, mechanical properties and antibacterial activity. J Mol Struct 2020. [DOI: 10.1016/j.molstruc.2020.128932] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
21
|
Chanyalew M, Abebe M, Endale B, Girma S, Tasew G, van Zandbergen G, Ritter U, Gadisa E, Aseffa A, Laskay T. Enhanced production of pro-inflammatory cytokines and chemokines in Ethiopian cutaneous leishmaniasis upon exposure to Leishmania aethiopica. Cytokine 2020; 145:155289. [PMID: 32951968 DOI: 10.1016/j.cyto.2020.155289] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2020] [Revised: 09/02/2020] [Accepted: 09/06/2020] [Indexed: 11/18/2022]
Abstract
The clinical course and outcome of cutaneous leishmaniasis (CL) vary due to the infecting Leishmania species and host genetic makeup that result in different immune responses against the parasites. The host immune response to Leishmania aethiopica (L.aethiopica), the causative agent of CL in Ethiopia, is poorly understood. To contribute to the understanding of the protective immune response in CL due to L.aethiopica, we characterized the cytokine response to L. aethiopica in patients with the localized form of CL (LCL) and age-and sex-matched apparently healthy controls. By applying a whole blood based in vitro culture we found enhanced release of TNF, IL-6, MCP-1 or CCL2, IP-10 or CXCL10, MIP-1β or CCL4 and IL-8 or CXCL8- but not of IL-10CL patients in response to L. aethiopica compared to the controls. No difference was observed between LCL cases and controls in the secretion of these cytokines and chemokines in whole blood cultures treated with the TLR-ligands LPS, MALP-2 or polyI: C. The observed increased secretion of the pro-inflammatory cytokines/chemokines reflects an enhanced response against the parasites by LCL patients as compared to healthy controls rather than a generally enhanced ability of blood leukocytes from LCL patients to respond to microbial constituents. Our findings suggest that the enhanced production of pro-inflammatory cytokines/chemokines is associated with localized cutaneous leishmaniasis caused by L.aethiopica.
Collapse
Affiliation(s)
- Menberework Chanyalew
- Research and Innovation Division, Armauer Hansen Research Institute, P.O. Box 1005, Addis Ababa, Ethiopia.
| | - Markos Abebe
- Research and Innovation Division, Armauer Hansen Research Institute, P.O. Box 1005, Addis Ababa, Ethiopia
| | - Birtukan Endale
- Research and Innovation Division, Armauer Hansen Research Institute, P.O. Box 1005, Addis Ababa, Ethiopia
| | - Selfu Girma
- Research and Innovation Division, Armauer Hansen Research Institute, P.O. Box 1005, Addis Ababa, Ethiopia
| | - Geremew Tasew
- Research and Innovation Division, Armauer Hansen Research Institute, P.O. Box 1005, Addis Ababa, Ethiopia; Leishmaniasis Research Laboratory, Ethiopia Public Health Institute, P.O. Box 1242, Addis Ababa, Ethiopia
| | - Ger van Zandbergen
- Division of Immunology, Paul-Ehrlich-Institute, Federal Institute for Vaccines and Biomedicines, Langen D-63225, Germany.
| | - Uwe Ritter
- Regensburg Center for Interventional Immunology (RCI), Institute of Immunology, University Medical Center Regensburg, University of Regensburg, D-93053 Regensburg, Germany.
| | - Endalamaw Gadisa
- Research and Innovation Division, Armauer Hansen Research Institute, P.O. Box 1005, Addis Ababa, Ethiopia
| | - Abraham Aseffa
- Research and Innovation Division, Armauer Hansen Research Institute, P.O. Box 1005, Addis Ababa, Ethiopia
| | - Tamás Laskay
- Department of Infectious Diseases and Microbiology, University of Lübeck, D-23560 Lübeck, Germany.
| |
Collapse
|
22
|
Hurmach Y, Rudyk M, Prylutska S, Hurmach V, Prylutskyy YI, Ritter U, Scharff P, Skivka L. C 60 Fullerene Governs Doxorubicin Effect on Metabolic Profile of Rat Microglial Cells In Vitro. Mol Pharm 2020; 17:3622-3632. [PMID: 32673486 DOI: 10.1021/acs.molpharmaceut.0c00691] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Background: C60 fullerenes and their derivatives are actively investigated for the use in neuroscience. Applications of these nanoscale materials require the examination of their interaction with different neural cells, especially with microglia, because these cells, like other tissue resident phagocytes, are the earliest and most sensitive responders to nanoparticles. The aim of this study was to investigate the effect of C60 fullerene and its nanocomplex with doxorubicin (Dox) on the metabolic profile of brain-resident phagocytes-microglia-in vitro. Methods: Resting microglial cells from adult male Wistar rats were used in experiments. Potential C60 fullerene targets in microglial cells were studied by computer simulation. Microglia oxidative metabolism and phagocytic activity were examined by flow cytometry. Griess reaction and arginase activity colorimetric assay were used to explore arginine metabolism. Results: C60 fullerene when used alone did not influence microglia oxidative metabolism and phagocytic activity but shifted arginine metabolism toward the decrease of NO generation. Complexation of C60 fullerene with Dox (C60-Dox) potentiated the ability of the latter to stimulate NO generation. Conclusion: The capability of C60 fullerenes used alone to cause anti-inflammatory shift of microglia arginine metabolism makes them a promising agent for the correction of neuroinflammatory processes involved in neurodegeneration. The potentiating action of C60 fullerene on the immunomodulatory effect of Dox allows us to consider the C60 molecule as an attractive vehicle for this antitumor agent.
Collapse
Affiliation(s)
- Yevheniia Hurmach
- Bogomolets National Medical University, 13, T. Shevchenko blvd, 01601 Kyiv, Ukraine
| | - Mariia Rudyk
- Taras Shevchenko National University of Kyiv, Volodymyrska str., 64, 01601 Kyiv, Ukraine
| | - Svitlana Prylutska
- Taras Shevchenko National University of Kyiv, Volodymyrska str., 64, 01601 Kyiv, Ukraine
| | - Vasyl Hurmach
- Taras Shevchenko National University of Kyiv, Volodymyrska str., 64, 01601 Kyiv, Ukraine
| | - Yuriy I Prylutskyy
- Taras Shevchenko National University of Kyiv, Volodymyrska str., 64, 01601 Kyiv, Ukraine
| | - Uwe Ritter
- Institute of Chemistry and Biotechnology, Technical University of Ilmenau, Weimarer Str., 25, 98693 Ilmenau, Germany
| | - Peter Scharff
- Institute of Chemistry and Biotechnology, Technical University of Ilmenau, Weimarer Str., 25, 98693 Ilmenau, Germany
| | - Larysa Skivka
- Taras Shevchenko National University of Kyiv, Volodymyrska str., 64, 01601 Kyiv, Ukraine
| |
Collapse
|
23
|
Kuznietsova H, Dziubenko N, Herheliuk T, Prylutskyy Y, Tauscher E, Ritter U, Scharff P. Water-Soluble Pristine C 60 Fullerene Inhibits Liver Alterations Associated with Hepatocellular Carcinoma in Rat. Pharmaceutics 2020; 12:pharmaceutics12090794. [PMID: 32842595 PMCID: PMC7559840 DOI: 10.3390/pharmaceutics12090794] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2020] [Revised: 08/15/2020] [Accepted: 08/19/2020] [Indexed: 12/11/2022] Open
Abstract
Excessive production of reactive oxygen species is the main cause of hepatocellular carcinoma (HCC) initiation and progression. Water-soluble pristine C60 fullerene is a powerful and non-toxic antioxidant, therefore, its effect under rat HCC model and its possible mechanisms were aimed to be discovered. Studies on HepG2 cells (human HCC) demonstrated C60 fullerene ability to inhibit cell growth (IC50 = 108.2 μmol), to induce apoptosis, to downregulate glucose-6-phosphate dehydrogenase, to upregulate vimentin and p53 expression and to alter HepG2 redox state. If applied to animals experienced HCC in dose of 0.25 mg/kg per day starting at liver cirrhosis stage, C60 fullerene improved post-treatment survival similar to reference 5-fluorouracil (31 and 30 compared to 17 weeks) and inhibited metastasis unlike the latter. Furthermore, C60 fullerene substantially attenuated liver injury and fibrosis, decreased liver enzymes, and normalized bilirubin and redox markers (elevated by 1.7–7.7 times under HCC). Thus, C60 fullerene ability to inhibit HepG2 cell growth and HCC development and metastasis and to improve animal survival was concluded. C60 fullerene cytostatic action might be realized through apoptosis induction and glucose-6-phosphate dehydrogenase downregulation in addition to its antioxidant activity.
Collapse
Affiliation(s)
- Halyna Kuznietsova
- Institute of Biology and Medicine, Taras Shevchenko National University of Kyiv, Volodymyrska str., 64, 01601 Kyiv, Ukraine; (N.D.); (T.H.); (Y.P.)
- Correspondence: (H.K.); (U.R.); Tel.: +38-095-277-4370 (H.K.); +49-3677-69-3603 (U.R.)
| | - Natalia Dziubenko
- Institute of Biology and Medicine, Taras Shevchenko National University of Kyiv, Volodymyrska str., 64, 01601 Kyiv, Ukraine; (N.D.); (T.H.); (Y.P.)
| | - Tetiana Herheliuk
- Institute of Biology and Medicine, Taras Shevchenko National University of Kyiv, Volodymyrska str., 64, 01601 Kyiv, Ukraine; (N.D.); (T.H.); (Y.P.)
| | - Yuriy Prylutskyy
- Institute of Biology and Medicine, Taras Shevchenko National University of Kyiv, Volodymyrska str., 64, 01601 Kyiv, Ukraine; (N.D.); (T.H.); (Y.P.)
| | - Eric Tauscher
- Institute of Chemistry and Biotechnology, Technical University of Ilmenau, Weimarer str. 25, 98693 Ilmenau, Germany; (E.T.); (P.S.)
| | - Uwe Ritter
- Institute of Chemistry and Biotechnology, Technical University of Ilmenau, Weimarer str. 25, 98693 Ilmenau, Germany; (E.T.); (P.S.)
- Correspondence: (H.K.); (U.R.); Tel.: +38-095-277-4370 (H.K.); +49-3677-69-3603 (U.R.)
| | - Peter Scharff
- Institute of Chemistry and Biotechnology, Technical University of Ilmenau, Weimarer str. 25, 98693 Ilmenau, Germany; (E.T.); (P.S.)
| |
Collapse
|
24
|
Tasew G, Gadisa E, Abera A, Chanyalew M, Abebe M, Howe R, Ritter U, Aseffa A, Laskay T. Whole blood-based in vitro culture reveals diminished secretion of pro-inflammatory cytokines and chemokines in visceral leishmaniasis. Cytokine 2020; 145:155246. [PMID: 32828639 DOI: 10.1016/j.cyto.2020.155246] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2020] [Revised: 07/18/2020] [Accepted: 08/08/2020] [Indexed: 11/28/2022]
Abstract
The likelihood of being bitten by sand flies infected with Leishmania (L.) donovani is considered to be high for all inhabitants living in the endemic areas, but only a small ratio of the population develop symptomatic visceral leishmanisis (VL). Since adequate activation of antimicrobial immune response plays a key role in control of pathogens early after infection we hypothesized that a dysfunction of essential cells of the immune system is associated with disease development after infection with L. donovani. In order to obtain insights into the capacity of leukocytes to respond to L. donovani, a whole blood based assay was applied to evaluate the production of cytokines and chemokines in clinical VL versus Ethiopian endemic healthy control (EHC). In response to L. donovani, VL blood cultures showed significantly lower secretion of IL-12p70, IL-6, IL-17, IL-8 and IP-10 compared to EHC. On the contrary, there was a significantly higher secretion of IL-10 observed in VL compared to EHC. In response to LPS also a lower IL-1β, IL-12p70 and IL-6 secretion was observed in VL as compared to EHC. The data clearly indicate a diminished ability of blood leukocytes in VL to respond to L. donovani and to the TLR ligand LPS. This compromised response in VL may contribute to the severe disease development and enhanced susceptibility to secondary infections in VL.
Collapse
Affiliation(s)
- Geremew Tasew
- Ethiopian Public Health Institute, Bacterial, Parasitic and Zoonotic Diseases Research Directorate, P.O. Box 1242, Addis Ababa, Ethiopia.
| | - Endalamaw Gadisa
- Armauer Hansen Research Institute, Neglected Tropical Diseases and Malaria Research Team, P.O. Box 1005, Addis Ababa, Ethiopia
| | - Adugna Abera
- Ethiopian Public Health Institute, Bacterial, Parasitic and Zoonotic Diseases Research Directorate, P.O. Box 1242, Addis Ababa, Ethiopia
| | - Menberework Chanyalew
- Armauer Hansen Research Institute, Neglected Tropical Diseases and Malaria Research Team, P.O. Box 1005, Addis Ababa, Ethiopia
| | - Markos Abebe
- Armauer Hansen Research Institute, Neglected Tropical Diseases and Malaria Research Team, P.O. Box 1005, Addis Ababa, Ethiopia
| | - Rawleigh Howe
- Armauer Hansen Research Institute, Neglected Tropical Diseases and Malaria Research Team, P.O. Box 1005, Addis Ababa, Ethiopia
| | - Uwe Ritter
- Regensburg Center for Interventional Immunology (RCI), Institute of Immunology, University Medical Center Regensburg and University of Regensburg, Regensburg, Germany
| | - Abraham Aseffa
- Armauer Hansen Research Institute, Neglected Tropical Diseases and Malaria Research Team, P.O. Box 1005, Addis Ababa, Ethiopia
| | - Tamás Laskay
- Department of Infectious Diseases and Microbiology, University of Lübeck, Ratzeburger Allee 160, D-23560 Lübeck, Germany
| |
Collapse
|
25
|
Halenova T, Raksha N, Savchuk O, Ostapchenko L, Prylutskyy Y, Ritter U, Scharff P. Evaluation of the Biocompatibility of Water-Soluble Pristine С60 Fullerenes in Rabbit. BioNanoSci 2020. [DOI: 10.1007/s12668-020-00762-w] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
26
|
Strandt H, Voluzan O, Niedermair T, Ritter U, Thalhamer J, Malissen B, Stoecklinger A, Henri S. Macrophages and Fibroblasts Differentially Contribute to Tattoo Stability. Dermatology 2020; 237:296-302. [PMID: 32344413 DOI: 10.1159/000506540] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2019] [Accepted: 02/17/2020] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND Little information is available about the complexity and function of skin cells contributing to the high stability of tattoos. It has been shown that dermal macrophages play an important role in the storage and maintenance of pigment particles. By contrast, the impact of dermal fibroblasts, forming the connective tissue of the skin, on the stability of the tattoo is not known. METHOD In this study, we compared the cell number and the particle load in dermal macrophages versus dermal fibroblasts, isolated from tail skin of tattooed mice. RESULTS Microscopic analysis revealed that both cell populations contained the tattoo particles, although in largely different amounts. A small number of macrophages with high side scatter intensity contained a large quantity of pigment particles, whereas a high number of dermal fibroblasts harbored only a few pigment particles. Using the CD64dtr mouse model that allows for selective, diphtheria toxin-mediated depletion of macrophages, we have previously shown that macrophages hold the tattoo in place by capture-release and recapture cycles. In the tattooed skin of macrophage-depleted mice, the content of pigment particles in fibroblasts did not change; however, the total number of fibroblasts carrying particles increased. CONCLUSION The present study demonstrates that dermal macrophages and fibroblasts contribute in different ways to the tattoo stability and further improves our knowledge on tattoo persistence.
Collapse
Affiliation(s)
- Helen Strandt
- Department of Biosciences, University of Salzburg, Salzburg, Austria
| | - Odessa Voluzan
- Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, INSERM, CNRS, Marseille, France
| | - Tanja Niedermair
- Department of Orthopaedic Surgery, University of Regensburg, Regensburg, Germany
| | - Uwe Ritter
- Department of Immunology, University of Regensburg, Regensburg, Germany
| | - Josef Thalhamer
- Department of Biosciences, University of Salzburg, Salzburg, Austria
| | - Bernard Malissen
- Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, INSERM, CNRS, Marseille, France.,Centre d'Immunophénomique, Aix Marseille Université, INSERM, CNRS, Marseille, France
| | | | - Sandrine Henri
- Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, INSERM, CNRS, Marseille, France,
| |
Collapse
|
27
|
Maznychenko AV, Mankivska OP, Sokolowska (Vereshchaka) IV, Kopyak BS, Tomiak T, Bulgakova NV, Gonchar OO, Prylutskyy YI, Ritter U, Mishchenko IV, Kostyukov AI. C60 fullerenes increase the intensity of rotational movements in non-anesthetized hemiparkinsonic rats. Acta Neurobiol Exp (Wars) 2020. [DOI: 10.21307/ane-2020-003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
28
|
Maznychenko AV, Mankivska OP, Sokolowska Vereshchaka IV, Kopyak BS, Tomiak T, Bulgakova NV, Gonchar OO, Prylutskyy YI, Ritter U, Mishchenko IV, Kostyukov AI. C60 fullerenes increase the intensity of rotational movements in non‑anesthetized hemiparkinsonic rats. Acta Neurobiol Exp (Wars) 2020; 80:32-37. [PMID: 32214272] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
The effect of C60 fullerene aqueous colloid solution (C60FAS) on the intensity of long‑lasting (persisting for one hour) rotational movements in non‑anesthetized rats was investigated. For this purpose, an experimental hemiparkinsonic animal model was used in the study. Rotational movements in hemiparkinsonic animals were initiated by the intraperitoneal administration of the dopamine receptor agonist apomorphine. It was shown that a preliminary injection of C60FAS (a substance with powerful antioxidant properties) in hemiparkinsonic rats induced distinct changes in animal motor behavior. It was revealed that fullerene‑pretreated animals, in comparison with non‑pretreated or vehicle‑pretreated rats, rotated for 1 h at an approximately identical speed until the end of the experiment, whereas the rotation speed of control rats gradually decreased to 20-30% of the initial value. One can assume that the observed changes in the movement dynamics of the hemiparkinsonic rats after C60FAS pretreatment presumably can be induced by the influence of C60FAS on the dopaminergic system, although the isolated potentiation of the action of apomorphine C60FAS cannot be excluded. Nevertheless, earlier data on the action of C60FAS on muscle dynamics has suggested that C60FAS can activate a protective action of the antioxidant system in response to long‑lasting muscular activity and that the antioxidant system in turn may directly decrease fatigue‑relate d changes during long‑lasting muscular activity.
Collapse
Affiliation(s)
- Andriy V Maznychenko
- Department of Movement Physiology, Bogomoletz Institute of Physiology, Kyiv, Ukraine,
- Department of Physical Education, Gdansk University of Physical Education and Sport, Gdańsk, Poland
| | - Olena P Mankivska
- Department of Cytology, Bogomoletz Institute of Physiology, Kyiv, Ukraine
| | | | - Bohdan S Kopyak
- Department of Blood Circulation, Bogomoletz Institute of Physiology, Kyiv, Ukraine
| | - Tomasz Tomiak
- Department of Physical Education, Gdansk University of Physical Education and Sport, Gdańsk, Poland
| | - Nataliya V Bulgakova
- Department of Movement Physiology, Bogomoletz Institute of Physiology, Kyiv, Ukraine
| | - Olga O Gonchar
- Department of Hypoxic States Investigation, Bogomoletz Institute of Physiology, Kyiv, Ukraine
| | - Yuriy I Prylutskyy
- Taras Shevchenko National University of Kyiv, ESC "Institute of Biology and Medicine", Kyiv, Ukraine
| | - Uwe Ritter
- Institute of Chemistry and Biotechnology, Technical University of Ilmenau, Ilmenau, Germany
| | | | - Alexander I Kostyukov
- Department of Movement Physiology, Bogomoletz Institute of Physiology, Kyiv, Ukraine
| |
Collapse
|
29
|
Prylutska SV, Lynchak OV, Kostjukov VV, Evstigneev MP, Remeniak OV, Rybalchenko VK, Prylutskyy YI, Ritter U, Scharff P. Antitumor effects and hematotoxicity of C 60-Cis-Pt nanocomplex in mice with Lewis lung carcinoma. Exp Oncol 2019; 41:106-111. [PMID: 31262160 DOI: 10.32471/exp-oncology.2312-8852.vol-41-no-2.13030] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
BACKGROUND Cisplatin (Cis-Pt) is a widely used anticancer drug but its therapeutic efficiency is limited by hemato-, cardio-, hepato-, nephro- and neurotoxicity. Complexation of Cis-Pt with C60 fullerene nanoparticle will allow to enhance the antitumor activity of the drug and to reduce its side toxic effects. AIM To estimate the antitumor effects of С60-Cis-Pt nanocomplex in Lewis lung carcinoma (LLC) and analyze hematological toxicity in tumor-bearing mice. MATERIALS AND METHODS Complexation of C60 fullerene and Cis-Pt molecule was studied by computer simulation. С60-Cis-Pt nanocomplex was i.p. injected to LLC-bearing mice in a total dose of 7.5 mg/kg (C60:Cis-Pt as 3.75:3.75 mg/kg). The survival of tumor-bearing mice and the relative reduction of tumor weight was recorded. Blood indices were determined using the Particle Counter PCE-210 automatic hematology analyzer. RESULTS Computer simulation demonstrated the formation of С60-Cis-Pt nanocomplex in physiological medium and its stability due to the hydrophobic interactions. Treatment with C60-Cis-Pt nanocomplex increased survival time of LLC-bearing mice by 32%, normalized hemoglobin content (up to 100 g/l), erythrocyte and platelet count as compared to the untreated LLC-bearing mice. Tumor weight decreased by 35.5%; the mitotic index of tumor cells decreased by 78%, and apoptotic index increased by 75%. The revealed effects of the C60-Cis-Pt nanocomplex were more pronounced than the effects of Cis-Pt or C60 fullerene alone in equivalent dose. CONCLUSION Treatment with C60-Cis-Pt nanocomplex prolonged the survival of LLC-bearing mice and reduced anemia in LLC-bearing mice.
Collapse
Affiliation(s)
- S V Prylutska
- Joint Ukrainian-German Center on Nanobiotechnology, Taras Shevchenko National University of Kyiv, Kyiv 01601, Ukraine
| | - O V Lynchak
- Joint Ukrainian-German Center on Nanobiotechnology, Taras Shevchenko National University of Kyiv, Kyiv 01601, Ukraine
| | - V V Kostjukov
- Belgorod State University, Belgorod 308015, Russian Federation
| | - M P Evstigneev
- Belgorod State University, Belgorod 308015, Russian Federation
| | - O V Remeniak
- National Pirogov Memorial Medical University, Vinnytsya 21018, Ukraine
| | - V K Rybalchenko
- Joint Ukrainian-German Center on Nanobiotechnology, Taras Shevchenko National University of Kyiv, Kyiv 01601, Ukraine
| | - Yu I Prylutskyy
- Joint Ukrainian-German Center on Nanobiotechnology, Taras Shevchenko National University of Kyiv, Kyiv 01601, Ukraine
| | - U Ritter
- Joint Ukrainian-German Center on Nanobiotechnology, Technical University of Ilmenau, Ilmenau 98693, Germany
| | - P Scharff
- Joint Ukrainian-German Center on Nanobiotechnology, Technical University of Ilmenau, Ilmenau 98693, Germany
| |
Collapse
|
30
|
Crauwels P, Bank E, Walber B, Wenzel UA, Agerberth B, Chanyalew M, Abebe M, König R, Ritter U, Reiling N, van Zandbergen G. Cathelicidin Contributes to the Restriction of Leishmania in Human Host Macrophages. Front Immunol 2019; 10:2697. [PMID: 31824492 PMCID: PMC6883804 DOI: 10.3389/fimmu.2019.02697] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2019] [Accepted: 11/01/2019] [Indexed: 11/30/2022] Open
Abstract
In cutaneous Leishmaniasis the parasitic control in human host macrophages is still poorly understood. We found an increased expression of the human cathelicidin CAMP in skin lesions of Ethiopian patients with cutaneous leishmaniasis. Vitamin D driven, Cathelicidin-type antimicrobial peptides (CAMP) play an important role in the elimination of invading microorganisms. Recombinant cathelicidin was able to induce cell-death characteristics in Leishmania in a dose dependent manner. Using human primary macrophages, we demonstrated pro-inflammatory macrophages (hMDM1) to express a higher level of human cathelicidin, both on gene and protein level, compared to anti-inflammatory macrophages (hMDM2). Activating the CAMP pathway using Vitamin D in hMDM1 resulted in a cathelicidin-mediated-Leishmania restriction. Finally, a reduction of cathelicidin in hMDM1, using a RNA interference (RNAi) approach, increased Leishmania parasite survival. In all, these data show the human cathelicidin to contribute to the innate immune response against Leishmaniasis in a human primary cell model.
Collapse
Affiliation(s)
- Peter Crauwels
- Division of Immunology, Paul-Ehrlich-Institute, Federal Institute for Vaccines and Biomedicines, Langen, Germany.,Institute for Microbiology and Biotechnology, University of Ulm, Ulm, Germany.,Institute for Medical Microbiology and Hygiene, University Clinic of Ulm, Ulm, Germany
| | - Elena Bank
- Division of Immunology, Paul-Ehrlich-Institute, Federal Institute for Vaccines and Biomedicines, Langen, Germany.,Institute for Medical Microbiology and Hygiene, University Clinic of Ulm, Ulm, Germany
| | - Bianca Walber
- Division of Immunology, Paul-Ehrlich-Institute, Federal Institute for Vaccines and Biomedicines, Langen, Germany
| | - Ulf Alexander Wenzel
- Institute for Medical Microbiology and Hygiene, University Clinic of Ulm, Ulm, Germany.,Department of Microbiology and Immunology, Mucosal Immunobiology and Vaccine Center (MIVAC), Institute of Biomedicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | - Birgitta Agerberth
- Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
| | - Menberework Chanyalew
- Research and Innovation Directorate, Armauer Hansen Research Institute (AHRI), Addis Ababa, Ethiopia
| | - Markos Abebe
- Research and Innovation Directorate, Armauer Hansen Research Institute (AHRI), Addis Ababa, Ethiopia
| | - Renate König
- Research Group "Host-Pathogen Interactions", Paul-Ehrlich-Institute, Federal Institute for Vaccines and Biomedicines, Langen, Germany
| | - Uwe Ritter
- Regensburg Center for Interventional Immunology (RCI), Institute of Immunology, University Medical Center Regensburg and University of Regensburg, Regensburg, Germany
| | - Norbert Reiling
- Division of Microbial Interface Biology, Research Center Borstel, Leibniz Center for Medicine and Biosciences, Borstel, Germany
| | - Ger van Zandbergen
- Division of Immunology, Paul-Ehrlich-Institute, Federal Institute for Vaccines and Biomedicines, Langen, Germany.,Institute for Medical Microbiology and Hygiene, University Clinic of Ulm, Ulm, Germany.,Institute of Immunology, Johannes Gutenberg University, Mainz, Germany.,Research Center for Immunotherapy (FZI), University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany
| |
Collapse
|
31
|
Grebinyk A, Prylutska S, Buchelnikov A, Tverdokhleb N, Grebinyk S, Evstigneev M, Matyshevska O, Cherepanov V, Prylutskyy Y, Yashchuk V, Naumovets A, Ritter U, Dandekar T, Frohme M. C 60 Fullerene as an Effective Nanoplatform of Alkaloid Berberine Delivery into Leukemic Cells. Pharmaceutics 2019; 11:pharmaceutics11110586. [PMID: 31717305 PMCID: PMC6920783 DOI: 10.3390/pharmaceutics11110586] [Citation(s) in RCA: 23] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2019] [Revised: 11/04/2019] [Accepted: 11/05/2019] [Indexed: 12/20/2022] Open
Abstract
A herbal alkaloid Berberine (Ber), used for centuries in Ayurvedic, Chinese, Middle-Eastern, and native American folk medicines, is nowadays proved to function as a safe anticancer agent. Yet, its poor water solubility, stability, and bioavailability hinder clinical application. In this study, we have explored a nanosized carbon nanoparticle-C60 fullerene (C60)-for optimized Ber delivery into leukemic cells. Water dispersions of noncovalent C60-Ber nanocomplexes in the 1:2, 1:1, and 2:1 molar ratios were prepared. UV-Vis spectroscopy, dynamic light scattering (DLS), and atomic force microscopy (AFM) evidenced a complexation of the Ber cation with the negatively charged C60 molecule. The computer simulation showed that π-stacking dominates in Ber and C60 binding in an aqueous solution. Complexation with C60 was found to promote Ber intracellular uptake. By increasing C60 concentration, the C60-Ber nanocomplexes exhibited higher antiproliferative potential towards CCRF-CEM cells, in accordance with the following order: free Ber < 1:2 < 1:1 < 2:1 (the most toxic). The activation of caspase 3/7 and accumulation in the sub-G1 phase of CCRF-CEM cells treated with C60-Ber nanocomplexes evidenced apoptosis induction. Thus, this study indicates that the fast and easy noncovalent complexation of alkaloid Ber with C60 improved its in vitro efficiency against cancer cells.
Collapse
Affiliation(s)
- Anna Grebinyk
- Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745 Wildau, Germany; (A.G.); s (S.G.)
- Department of Bioinformatics, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany;
| | - Svitlana Prylutska
- Taras Shevchenko National University of Kyiv, Volodymyrska 64, 01601 Kyiv, Ukraine; (S.P.); (Y.P.); (V.Y.)
| | - Anatoliy Buchelnikov
- Laboratory of Molecular and Cell Biophysics, Sevastopol State University, 299053 Sevastopol, Crimea; (A.B.); (N.T.); (M.E.)
| | - Nina Tverdokhleb
- Laboratory of Molecular and Cell Biophysics, Sevastopol State University, 299053 Sevastopol, Crimea; (A.B.); (N.T.); (M.E.)
| | - Sergii Grebinyk
- Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745 Wildau, Germany; (A.G.); s (S.G.)
| | - Maxim Evstigneev
- Laboratory of Molecular and Cell Biophysics, Sevastopol State University, 299053 Sevastopol, Crimea; (A.B.); (N.T.); (M.E.)
- Laboratory of Organic Synthesis and NMR Spectroscopy, Belgorod State University, 308015 Belgorod, Russia
| | - Olga Matyshevska
- Palladin Institute of Biochemistry, NAS of Ukraine, Leontovicha Str. 9, 01030 Kyiv, Ukraine;
| | - Vsevolod Cherepanov
- Institute of Physics, NAS of Ukraine, 46 av. Nauki, 03028 Kyiv, Ukraine; (V.C.); (A.N.)
| | - Yuriy Prylutskyy
- Taras Shevchenko National University of Kyiv, Volodymyrska 64, 01601 Kyiv, Ukraine; (S.P.); (Y.P.); (V.Y.)
| | - Valeriy Yashchuk
- Taras Shevchenko National University of Kyiv, Volodymyrska 64, 01601 Kyiv, Ukraine; (S.P.); (Y.P.); (V.Y.)
| | - Anton Naumovets
- Institute of Physics, NAS of Ukraine, 46 av. Nauki, 03028 Kyiv, Ukraine; (V.C.); (A.N.)
| | - Uwe Ritter
- Institute of Chemistry and Biotechnology, University of Technology Ilmenau, Weimarer Straße 25 (Curiebau), 98693 Ilmenau, Germany;
| | - Thomas Dandekar
- Department of Bioinformatics, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany;
| | - Marcus Frohme
- Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745 Wildau, Germany; (A.G.); s (S.G.)
- Correspondence: ; Tel.: +49-(0)-3375-508-249
| |
Collapse
|
32
|
Grebinyk A, Prylutska S, Chepurna O, Grebinyk S, Prylutskyy Y, Ritter U, Ohulchanskyy TY, Matyshevska O, Dandekar T, Frohme M. Synergy of Chemo- and Photodynamic Therapies with C 60 Fullerene-Doxorubicin Nanocomplex. Nanomaterials (Basel) 2019; 9:nano9111540. [PMID: 31671590 PMCID: PMC6915635 DOI: 10.3390/nano9111540] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/30/2019] [Revised: 10/22/2019] [Accepted: 10/27/2019] [Indexed: 12/17/2022]
Abstract
A nanosized drug complex was explored to improve the efficiency of cancer chemotherapy, complementing it with nanodelivery and photodynamic therapy. For this, nanomolar amounts of a non-covalent nanocomplex of Doxorubicin (Dox) with carbon nanoparticle C60 fullerene (C60) were applied in 1:1 and 2:1 molar ratio, exploiting C60 both as a drug-carrier and as a photosensitizer. The fluorescence microscopy analysis of human leukemic CCRF-CEM cells, in vitro cancer model, treated with nanocomplexes showed Dox’s nuclear and C60’s extranuclear localization. It gave an opportunity to realize a double hit strategy against cancer cells based on Dox’s antiproliferative activity and C60’s photoinduced pro-oxidant activity. When cells were treated with 2:1 C60-Dox and irradiated at 405 nm the high cytotoxicity of photo-irradiated C60-Dox enabled a nanomolar concentration of Dox and C60 to efficiently kill cancer cells in vitro. The high pro-oxidant and pro-apoptotic efficiency decreased IC50 16, 9 and 7 × 103-fold, if compared with the action of Dox, non-irradiated nanocomplex, and C60’s photodynamic effect, correspondingly. Hereafter, a strong synergy of therapy arising from the combination of C60-mediated Dox delivery and C60 photoexcitation was revealed. Our data indicate that a combination of chemo- and photodynamic therapies with C60-Dox nanoformulation provides a promising synergetic approach for cancer treatment.
Collapse
Affiliation(s)
- Anna Grebinyk
- Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745 Wildau, Germany.
- Department of Bioinformatics, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany.
| | - Svitlana Prylutska
- Taras Shevchenko National University of Kyiv, Volodymyrska 64, 01601 Kyiv, Ukraine.
| | - Oksana Chepurna
- Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen 518060, China.
| | - Sergii Grebinyk
- Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745 Wildau, Germany.
| | - Yuriy Prylutskyy
- Taras Shevchenko National University of Kyiv, Volodymyrska 64, 01601 Kyiv, Ukraine.
| | - Uwe Ritter
- Institute of Chemistry and Biotechnology, University of Technology Ilmenau, Weimarer Straße 25 (Curiebau), 98693 Ilmenau, Germany.
| | - Tymish Y Ohulchanskyy
- Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen 518060, China.
| | - Olga Matyshevska
- Palladin Institute of Biochemistry, NAS of Ukraine, Leontovicha Str. 9, 01030 Kyiv, Ukraine.
| | - Thomas Dandekar
- Department of Bioinformatics, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany.
| | - Marcus Frohme
- Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745 Wildau, Germany.
| |
Collapse
|
33
|
Yasinskyi Y, O. P, O. M, V. R, Prylutskyy Y, Tauscher E, Ritter U, Kozeretska I. Reconciling the controversial data on the effects of C60 fullerene at the organismal and molecular levels using as a model Drosophila melanogaster. Toxicol Lett 2019; 310:92-98. [DOI: 10.1016/j.toxlet.2019.03.006] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2018] [Revised: 02/01/2019] [Accepted: 03/16/2019] [Indexed: 10/27/2022]
|
34
|
Ribechini E, Eckert I, Beilhack A, Du Plessis N, Walzl G, Schleicher U, Ritter U, Lutz MB. Heat-killed Mycobacterium tuberculosis prime-boost vaccination induces myeloid-derived suppressor cells with spleen dendritic cell-killing capability. JCI Insight 2019; 5:128664. [PMID: 31162143 DOI: 10.1172/jci.insight.128664] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022] Open
Abstract
Tuberculosis patients and mice infected with live Mycobacterium tuberculosis (Mtb) accumulate high numbers of myeloid-derived suppressor cells (MDSCs). Here, we hypothesized that also dead Mtb vaccines may induce MDSCs that could impair the efficacy of vaccination. We found that repeated injections of Mtb vaccines (heat-killed Mtb in Incomplete Freund's Adjuvant, like Montanide) but not single or control vaccines without Mtb strongly expanded CD11b+ myeloid cells in the spleen, that suppressed T cell proliferation and killing ex vivo. Dead Mtb vaccination induced the generation of CD11b+ Ly-6Chigh CD115+ iNOS/Nos2+ monocytic MDSCs (M-MDSCs) upon application of inflammatory or microbial activation signals. In vivo these M-MDSCs positioned strategically in the spleen by infiltrating the splenic bridging channels and white pulp areas. Notably, within 6 to 24 hours in a Nos2-dependent fashion they produced NO to rapidly kill conventional and plasmacytoid dendritic cells (cDCs, pDCs) while, surprisingly, sparing T cells in vivo. Thus, we demonstrate that Mtb vaccine induced M-MDSCs to not directly suppress T cell in vivo but, instead, M-MDSCs directly target DC subpopulations thereby indirectly suppressing effector T cell responses. Collectively, we demonstrate that Mtb booster vaccines induce M-MDSCs in the spleen that can be activated to kill DCs cautioning to thoroughly investigate MDSC formation in individuals after Mtb vaccination in clinical trials.
Collapse
Affiliation(s)
- Eliana Ribechini
- Institute of Virology and Immunobiology, University of Würzburg, Würzburg, Germany
| | - Ina Eckert
- Institute of Virology and Immunobiology, University of Würzburg, Würzburg, Germany
| | - Andreas Beilhack
- Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
| | - Nelita Du Plessis
- South African Medical Research Council, Centre for Tuberculosis Research, Department of Science and Technology - National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
| | - Gerhard Walzl
- South African Medical Research Council, Centre for Tuberculosis Research, Department of Science and Technology - National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
| | - Ulrike Schleicher
- Microbiology Institute, Clinical Microbiology, Immunology and Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| | - Uwe Ritter
- RCI Regensburg Center for Interventional Immunology, Institute of Immunology, University Medical Center Regensburg, University of Regensburg, Regensburg, Germany
| | - Manfred B Lutz
- Institute of Virology and Immunobiology, University of Würzburg, Würzburg, Germany
| |
Collapse
|
35
|
Franskevych D, Prylutska S, Grynyuk I, Pasichnyk G, Drobot L, Matyshevska O, Ritter U. Mode of photoexcited C 60 fullerene involvement in potentiating cisplatin toxicity against drug-resistant L1210 cells. ACTA ACUST UNITED AC 2019; 9:211-217. [PMID: 31799157 PMCID: PMC6879712 DOI: 10.15171/bi.2019.26] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2018] [Revised: 03/08/2019] [Accepted: 04/09/2019] [Indexed: 11/23/2022]
Abstract
![]()
Introduction: C60 fullerene has received great attention as a candidate for biomedical applications. Due to unique structure and properties, C60 fullerene nanoparticles are supposed to be useful in drug delivery, photodynamic therapy (PDT) of cancer, and reversion of tumor cells’ multidrug resistance. The aim of this study was to elucidate the possible molecular mechanisms involved in photoexcited C60 fullerene-dependent enhancement of cisplatin toxicity against leukemic cells resistant to cisplatin.
Methods: Stable homogeneous pristine C60 fullerene aqueous colloid solution (10-4 М, purity 99.5%) was used in the study. The photoactivation of C60 fullerene accumulated by L1210R cells was done by irradiation in microplates with light-emitting diode lamp (420-700 nm light, 100 mW·cm-2). Cells were further incubated with the addition of Cis-Pt to a final concentration of 1 μg/mL. Activation of p38 MAPK was visualized by Western blot analysis. Flow cytometry was used for the estimation of cells distribution on cell cycle. Mitochondrial membrane potential (Δψm) was estimated with the use of fluorescent potential-sensitive probe TMRE (Tetramethylrhodamine Ethyl Ester).
Results: Cis-Pt applied alone at 1 μg/mL concentration failed to affect mitochondrial membrane potential in L1210R cells or cell cycle distribution as compared with untreated cells. Activation of ROS-sensitive proapoptotic p38 kinase and enhanced content of cells in subG1 phase were detected after irradiation of L1210R cells treated with 10-5M C60 fullerene. Combined treatment with photoexcited C60 fullerene and Cis-Pt was followed by the dissipation of Δψm at early-term period, blockage of cell transition into S phase, and considerable accumulation of cells in proapoptotic subG1 phase at prolonged incubation.
Conclusion: The effect of the synergic cytotoxic activity of both agents allowed to suppose that photoexcited C60 fullerene promoted Cis-Pt accumulation in leukemic cells resistant to Cis-Pt. The data obtained could be useful for the development of new approaches to overcome drug-resistance of leukemic cells.
Collapse
Affiliation(s)
- Daria Franskevych
- Taras Shevchenko National University of Kyiv, Volodymyrska Str., 64, 01601 Kyiv, Ukraine
| | - Svitlana Prylutska
- Taras Shevchenko National University of Kyiv, Volodymyrska Str., 64, 01601 Kyiv, Ukraine
| | - Iryna Grynyuk
- Taras Shevchenko National University of Kyiv, Volodymyrska Str., 64, 01601 Kyiv, Ukraine
| | - Ganna Pasichnyk
- Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, Leontovicha Str, 9, Kyiv 01030, Ukraine
| | - Liudmyla Drobot
- Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, Leontovicha Str, 9, Kyiv 01030, Ukraine
| | - Olga Matyshevska
- Taras Shevchenko National University of Kyiv, Volodymyrska Str., 64, 01601 Kyiv, Ukraine.,Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, Leontovicha Str, 9, Kyiv 01030, Ukraine
| | - Uwe Ritter
- Technical University Ilmenau, Institute of Chemistry and Biotechnology, Weimarer Str., 25, 98693 Ilmenau, Germany
| |
Collapse
|
36
|
Kuznietsova H, Lynchak O, Dziubenko N, Herheliuk T, Prylutskyy Y, Rybalchenko V, Ritter U. Water-soluble pristine C 60 fullerene attenuates acetaminophen-induced liver injury. ACTA ACUST UNITED AC 2019; 9:227-237. [PMID: 31799159 PMCID: PMC6879707 DOI: 10.15171/bi.2019.28] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2019] [Revised: 03/19/2019] [Accepted: 04/16/2019] [Indexed: 12/19/2022]
Abstract
![]()
Introduction: Oxidative stress has been suggested as the main trigger and pathological mechanism of toxic liver injury. Effects of powerful free radical scavenger С60 fullerene on rat liver injury and liver cells (HepG2 line) were aimed to be discovered.
Methods: Acute liver injury (ALI) was simulated by single acetaminophen (APAP, 1000 mg/kg) administration, on a chronic CLI, by 4 weekly APAP administrations. Pristine C60 fullerene aqueous colloid solution (C60FAS; initial concentration 0.15 mg/mL) was administered per os or intraperitoneally at a dose of 0.5 mg/kg (ALI) or 0.25 mg/kg (CLI) daily for 2 or 28 days, respectively, after first APAP dose. Animals were sacrificed at 24th hour after the last dose. Biochemical markers of blood serum and liver autopsies were analyzed. EGFR expression in HepG2 cells after 48-hour incubation with C60FAS was assessed.
Results: Increase of serum conjugated and unconjugated bilirubin (up to 1.4-3.7 times), ALT (by 31-37%), and AST (by 18%) in non-treated ALI and CLI rats were observed, suggesting the hepatitis (confirmed by histological analysis). Liver morphological state (ALI, CLI), ALT (ALI and CLI), bilirubin (CLI), α-amylase, and creatinine (ALI) were normalized with C60FAS administration in both ways, which may indicate its protective impact on liver. However, unconjugated bilirubin sharply increased in ALI animals receiving C60FAS (up to 12 times compared to control), suggesting the augmentation of bilirubin metabolism. Furthermore, C60FAS inhibited EGFR expression in HepG2 cells in a dose-dependent manner.
Conclusion: C60FAS could partially correct acute and chronic toxic liver injury, however, it could not normalize bilirubin metabolism after acute exposure.
Collapse
Affiliation(s)
- Halyna Kuznietsova
- Taras Shevchenko National University of Kyiv, Institute of Biology and Medicine, 64 Volodymyrska Str., 01601 Kyiv, Ukraine
| | - Oksana Lynchak
- Taras Shevchenko National University of Kyiv, Institute of Biology and Medicine, 64 Volodymyrska Str., 01601 Kyiv, Ukraine
| | - Natalia Dziubenko
- Taras Shevchenko National University of Kyiv, Institute of Biology and Medicine, 64 Volodymyrska Str., 01601 Kyiv, Ukraine
| | - Tetyana Herheliuk
- Taras Shevchenko National University of Kyiv, Institute of Biology and Medicine, 64 Volodymyrska Str., 01601 Kyiv, Ukraine
| | - Yuriy Prylutskyy
- Taras Shevchenko National University of Kyiv, Institute of Biology and Medicine, 64 Volodymyrska Str., 01601 Kyiv, Ukraine
| | - Volodymyr Rybalchenko
- Taras Shevchenko National University of Kyiv, Institute of Biology and Medicine, 64 Volodymyrska Str., 01601 Kyiv, Ukraine
| | - Uwe Ritter
- Technical University of Ilmenau, Institute of Chemistry and Biotechnology, 25 Weimarer Str., 98693 Ilmenau, Germany
| |
Collapse
|
37
|
Prylutska S, Grynyuk I, Skaterna T, Horak I, Grebinyk A, Drobot L, Matyshevska O, Senenko A, Prylutskyy Y, Naumovets A, Ritter U, Frohme M. Toxicity of C 60 fullerene-cisplatin nanocomplex against Lewis lung carcinoma cells. Arch Toxicol 2019; 93:1213-1226. [PMID: 30989314 DOI: 10.1007/s00204-019-02441-6] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2019] [Accepted: 04/09/2019] [Indexed: 12/18/2022]
Abstract
Cisplatin (Cis-Pt) is the cytotoxic agent widely used against tumors of various origin, but its therapeutic efficiency is substantially limited by a non-selective effect and high toxicity. Conjugation of Cis-Pt with nanocarriers is thought to be one option to enable drug targeting. The aim of this study was to estimate toxic effects of the nanocomplex formed by noncovalent interaction of C60 fullerene with Cis-Pt against Lewis lung carcinoma (LLC) cells in comparison with free drug. Scanning tunneling microscopy showed that the minimum size of C60-Cis-Pt nanoparticles in aqueous colloid solution was 1.1 nm whereas that of C60 fullerene was 0.72 nm, thus confirming formation of the nanocomplex. The cytotoxic effect of C60-Cis-Pt nanocomplex against LLC cells was shown to be higher with IC50 values 3.3 and 4.5 times lower at 48 h and 72 h, respectively, as compared to the free drug. 12.5 µM Cis-Pt had no effect on LLC cell viability and morphology while C60-Cis-Pt nanocomplex in Cis-Pt-equivalent concentration substantially decreased the cell viability, impaired their shape and adhesion, inhibited migration and induced accumulation in proapoptotic subG1 phase. Apoptosis induced by the C60-Cis-Pt nanocomplex was confirmed by caspase 3/7 activation and externalization of phosphatidylserine on the outer surface of LLC cells with the double Annexin V-FITC/PI staining. We assume that C60 fullerene as a component of the C60-Cis-Pt nanocomplex promoted Cis-Pt entry and intracellular accumulation thus contributing to intensification of the drug's toxic effect against lung cancer cells.
Collapse
Affiliation(s)
- Svitlana Prylutska
- Taras Shevchenko National University of Kyiv, 64 Volodymyrska Str., Kyiv, 01601, Ukraine
| | - Iryna Grynyuk
- Taras Shevchenko National University of Kyiv, 64 Volodymyrska Str., Kyiv, 01601, Ukraine
| | - Tetiana Skaterna
- Palladin Institute of Biochemistry, NAS of Ukraine, 9 Leontovicha Str., Kyiv, 01030, Ukraine
| | - Iryna Horak
- Palladin Institute of Biochemistry, NAS of Ukraine, 9 Leontovicha Str., Kyiv, 01030, Ukraine
| | - Anna Grebinyk
- Taras Shevchenko National University of Kyiv, 64 Volodymyrska Str., Kyiv, 01601, Ukraine.,Technical University of Applied Sciences Wildau, 1 Hochschulring Str., 15745, Wildau, Germany
| | - Liudmyla Drobot
- Palladin Institute of Biochemistry, NAS of Ukraine, 9 Leontovicha Str., Kyiv, 01030, Ukraine
| | - Olga Matyshevska
- Taras Shevchenko National University of Kyiv, 64 Volodymyrska Str., Kyiv, 01601, Ukraine.,Palladin Institute of Biochemistry, NAS of Ukraine, 9 Leontovicha Str., Kyiv, 01030, Ukraine
| | - Anton Senenko
- Institute of Physics of the NAS of Ukraine, 46 Avenu Nauky, Kyiv, 03028, Ukraine
| | - Yuriy Prylutskyy
- Taras Shevchenko National University of Kyiv, 64 Volodymyrska Str., Kyiv, 01601, Ukraine
| | - Anton Naumovets
- Institute of Physics of the NAS of Ukraine, 46 Avenu Nauky, Kyiv, 03028, Ukraine
| | - Uwe Ritter
- Institute of Chemistry and Biotechnology, Technical University of Ilmenau, 25 Weimarer Str., 98693, Ilmenau, Germany
| | - Marcus Frohme
- Technical University of Applied Sciences Wildau, 1 Hochschulring Str., 15745, Wildau, Germany.
| |
Collapse
|
38
|
Melnyk MI, Ivanova IV, Dryn DO, Prylutskyy YI, Hurmach VV, Platonov M, Al Kury LT, Ritter U, Soloviev AI, Zholos AV. C 60 fullerenes selectively inhibit BK Ca but not K v channels in pulmonary artery smooth muscle cells. Nanomedicine 2019; 19:1-11. [PMID: 30981819 DOI: 10.1016/j.nano.2019.03.018] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/14/2018] [Revised: 02/20/2019] [Accepted: 03/19/2019] [Indexed: 01/12/2023]
Abstract
Possessing unique physical and chemical properties, C60 fullerenes are arising as a potential nanotechnological tool that can strongly affect various biological processes. Recent molecular modeling studies have shown that C60 fullerenes can interact with ion channels, but there is lack of data about possible effects of C60 molecule on ion channels expressed in smooth muscle cells (SMC). Here we show both computationally and experimentally that water-soluble pristine C60 fullerene strongly inhibits the large conductance Ca2+-dependent K+ (BKCa), but not voltage-gated K+ (Kv) channels in pulmonary artery SMC. Both molecular docking simulations and analysis of single channel activity indicate that C60 fullerene blocks BKCa channel pore in its open state. In functional tests, C60 fullerene enhanced phenylephrine-induced contraction of pulmonary artery rings by about 25% and reduced endothelium-dependent acetylcholine-induced relaxation by up to 40%. These findings suggest a novel strategy for biomedical application of water-soluble pristine C60 fullerene in vascular dysfunction.
Collapse
Affiliation(s)
- Mariia I Melnyk
- O.O. Bogomoletz Institute of Physiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine; Institute of Pharmacology and Toxicology, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
| | - Irina V Ivanova
- Institute of Pharmacology and Toxicology, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
| | - Dariia O Dryn
- O.O. Bogomoletz Institute of Physiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine; Institute of Pharmacology and Toxicology, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine; ESC "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Kyiv, Ukraine
| | - Yuriy I Prylutskyy
- ESC "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Kyiv, Ukraine
| | - Vasyl V Hurmach
- ESC "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Kyiv, Ukraine
| | - Maxim Platonov
- Institute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine, Kyiv, Ukraine
| | - Lina T Al Kury
- College of Natural and Health Sciences, Zayed University, Abu Dhabi, United Arab Emirates
| | - Uwe Ritter
- Technical University of Ilmenau, Institute of Chemistry and Biotechnology, Ilmenau, Germany
| | - Anatoly I Soloviev
- Institute of Pharmacology and Toxicology, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
| | - Alexander V Zholos
- O.O. Bogomoletz Institute of Physiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine; ESC "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.
| |
Collapse
|
39
|
Grebinyk A, Prylutska S, Grebinyk S, Prylutskyy Y, Ritter U, Matyshevska O, Dandekar T, Frohme M. Correction to: Complexation with C 60 Fullerene Increases Doxorubicin Efficiency against Leukemic Cells In Vitro. Nanoscale Res Lett 2019; 14:91. [PMID: 30868449 PMCID: PMC6419633 DOI: 10.1186/s11671-019-2917-y] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
Abstract
Following publication of the original article [1], the authors flagged that there was unfortunately an error with Fig. 3 of the article.
Collapse
Affiliation(s)
- Anna Grebinyk
- Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745, Wildau, Germany
- Taras Shevchenko National University of Kyiv, Volodymyrska 64, Kyiv, 01601, Ukraine
- Department of Bioinformatics, Biocenter, University of Würzburg, Am Hubland, 97074, Würzburg, Germany
| | - Svitlana Prylutska
- Taras Shevchenko National University of Kyiv, Volodymyrska 64, Kyiv, 01601, Ukraine
| | - Sergii Grebinyk
- Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745, Wildau, Germany
| | - Yuriy Prylutskyy
- Taras Shevchenko National University of Kyiv, Volodymyrska 64, Kyiv, 01601, Ukraine
| | - Uwe Ritter
- Institute of Chemistry and Biotechnology, University of Technology Ilmenau, Weimarer Straße 25 (Curiebau), 98693, Ilmenau, Germany
| | - Olga Matyshevska
- Taras Shevchenko National University of Kyiv, Volodymyrska 64, Kyiv, 01601, Ukraine
| | - Thomas Dandekar
- Department of Bioinformatics, Biocenter, University of Würzburg, Am Hubland, 97074, Würzburg, Germany
| | - Marcus Frohme
- Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745, Wildau, Germany.
| |
Collapse
|
40
|
Grebinyk A, Prylutska S, Grebinyk S, Prylutskyy Y, Ritter U, Matyshevska O, Dandekar T, Frohme M. Complexation with C 60 Fullerene Increases Doxorubicin Efficiency against Leukemic Cells In Vitro. Nanoscale Res Lett 2019; 14:61. [PMID: 30788638 PMCID: PMC6382919 DOI: 10.1186/s11671-019-2894-1] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/15/2018] [Accepted: 02/06/2019] [Indexed: 05/06/2023]
Abstract
Conventional anticancer chemotherapy is limited because of severe side effects as well as a quickly evolving multidrug resistance of the tumor cells. To address this problem, we have explored a C60 fullerene-based nanosized system as a carrier for anticancer drugs for an optimized drug delivery to leukemic cells.Here, we studied the physicochemical properties and anticancer activity of C60 fullerene noncovalent complexes with the commonly used anticancer drug doxorubicin. C60-Doxorubicin complexes in a ratio 1:1 and 2:1 were characterized with UV/Vis spectrometry, dynamic light scattering, and high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). The obtained analytical data indicated that the 140-nm complexes were stable and could be used for biological applications. In leukemic cell lines (CCRF-CEM, Jurkat, THP1 and Molt-16), the nanocomplexes revealed ≤ 3.5 higher cytotoxic potential in comparison with the free drug in a range of nanomolar concentrations. Also, the intracellular drug's level evidenced C60 fullerene considerable nanocarrier function.The results of this study indicated that C60 fullerene-based delivery nanocomplexes had a potential value for optimization of doxorubicin efficiency against leukemic cells.
Collapse
Affiliation(s)
- Anna Grebinyk
- Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745 Wildau, Germany
- Taras Shevchenko National University of Kyiv, Volodymyrska 64, Kyiv, 01601 Ukraine
- Department of Bioinformatics, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany
| | - Svitlana Prylutska
- Taras Shevchenko National University of Kyiv, Volodymyrska 64, Kyiv, 01601 Ukraine
| | - Sergii Grebinyk
- Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745 Wildau, Germany
| | - Yuriy Prylutskyy
- Taras Shevchenko National University of Kyiv, Volodymyrska 64, Kyiv, 01601 Ukraine
| | - Uwe Ritter
- Institute of Chemistry and Biotechnology, University of Technology Ilmenau, Weimarer Straße 25 (Curiebau), 98693 Ilmenau, Germany
| | - Olga Matyshevska
- Taras Shevchenko National University of Kyiv, Volodymyrska 64, Kyiv, 01601 Ukraine
| | - Thomas Dandekar
- Department of Bioinformatics, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany
| | - Marcus Frohme
- Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745 Wildau, Germany
| |
Collapse
|
41
|
Sukhodub L, Sukhodub L, Prylutskyy Y, Strutynska N, Vovchenko L, Soroca V, Slobodyanik N, Tsierkezos N, Ritter U. Composite material based on hydroxyapatite and multi-walled carbon nanotubes filled by iron: Preparation, properties and drug release ability. Materials Science and Engineering: C 2018; 93:606-614. [DOI: 10.1016/j.msec.2018.08.019] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/26/2018] [Revised: 07/12/2018] [Accepted: 08/06/2018] [Indexed: 01/23/2023]
|
42
|
Byelinska I, Kuznietsova H, Dziubenko N, Lynchak O, Rybalchenko T, Prylutskyy Y, Kyzyma O, Ivankov O, Rybalchenko V, Ritter U. Effect of С60 fullerenes on the intensity of colon damage and hematological signs of ulcerative colitis in rats. Materials Science and Engineering: C 2018; 93:505-517. [DOI: 10.1016/j.msec.2018.08.033] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/18/2017] [Revised: 07/06/2018] [Accepted: 08/11/2018] [Indexed: 02/07/2023]
|
43
|
Zavodovskyi DO, Zay SY, Matvienko TY, Prylutskyy YI, Nurishchenko NY, Paradizova SS, Bezuh LL, Ritter U, Scharff P. Influence of C(60) fullerene on the ischemia-reperfusion injury in the skeletal muscle of rat limb: mechanokinetic and biochemical analysis. Ukr Biochem J 2018. [DOI: 10.15407/ubj90.06.070] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
44
|
Skivka LM, Prylutska SV, Rudyk MP, Khranovska NM, Opeida IV, Hurmach VV, Prylutskyy YI, Sukhodub LF, Ritter U. C 60 fullerene and its nanocomplexes with anticancer drugs modulate circulating phagocyte functions and dramatically increase ROS generation in transformed monocytes. Cancer Nanotechnol 2018; 9:8. [PMID: 30416604 PMCID: PMC6208740 DOI: 10.1186/s12645-017-0034-0] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2017] [Accepted: 11/25/2017] [Indexed: 12/16/2022] Open
Abstract
Background C60 fullerene-based nanoformulations are proposed to have a direct toxic effect on tumor cells. Previous investigations demonstrated that C60 fullerene used alone or being conjugated with chemotherapeutic agents possesses a potent anticancer activity. The main aim of this study was to investigate the effect of C60 fullerene and its nanocomplexes with anticancer drugs on human phagocyte metabolic profile in vitro. Methods Analysis of the metabolic profile of phagocytes exposed to C60 fullerene in vitro revealed augmented phagocytic activity and down-regulated reactive nitrogen species generation in these cells. Additionally, cytofluorimetric analysis showed that C60 fullerene can exert direct cytotoxic effect on normal and transformed phagocytes through the vigorous induction of intracellular reactive oxygen species generation. Results Cytotoxic action as well as the pro-oxidant effect of C60 fullerene was more pronounced toward malignant phagocytes. At the same time, C60 fullerenes have the ability to down-regulate the pro-oxidant effect of cisplatin on normal cells. These results indicate that C60 fullerenes may influence phagocyte metabolism and have both pro-oxidant and antioxidant properties. Conclusions The antineoplastic effect of C60 fullerene has been observed by direct toxic effect on tumor cells, as well as through the modulation of the functions of effector cells of antitumor immunity.
Collapse
Affiliation(s)
- Larysa M Skivka
- 1Taras Shevchenko National University of Kyiv, 64 Volodymyrska str., Kiev, 01601 Ukraine
| | - Svitlana V Prylutska
- 1Taras Shevchenko National University of Kyiv, 64 Volodymyrska str., Kiev, 01601 Ukraine
| | - Mariia P Rudyk
- 1Taras Shevchenko National University of Kyiv, 64 Volodymyrska str., Kiev, 01601 Ukraine
| | | | - Ievgeniia V Opeida
- 1Taras Shevchenko National University of Kyiv, 64 Volodymyrska str., Kiev, 01601 Ukraine
| | - Vasyl V Hurmach
- 1Taras Shevchenko National University of Kyiv, 64 Volodymyrska str., Kiev, 01601 Ukraine
| | - Yuriy I Prylutskyy
- 1Taras Shevchenko National University of Kyiv, 64 Volodymyrska str., Kiev, 01601 Ukraine
| | - Leonid F Sukhodub
- 3Sumy State University, 2 Rymskogo-Korsakova str., Sumy, 40007 Ukraine
| | - Uwe Ritter
- 4Institute of Chemistry and Biotechnology, Technical University of Ilmenau, Weimarer str. 25, 98693 Ilmenau, Germany
| |
Collapse
|
45
|
Blazquez R, Wlochowitz D, Wolff A, Seitz S, Wachter A, Perera-Bel J, Bleckmann A, Beißbarth T, Salinas G, Riemenschneider MJ, Proescholdt M, Evert M, Utpatel K, Siam L, Schatlo B, Balkenhol M, Stadelmann C, Schildhaus HU, Korf U, Reinz E, Wiemann S, Vollmer E, Schulz M, Ritter U, Hanisch UK, Pukrop T. PI3K: A master regulator of brain metastasis-promoting macrophages/microglia. Glia 2018; 66:2438-2455. [PMID: 30357946 DOI: 10.1002/glia.23485] [Citation(s) in RCA: 52] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2018] [Revised: 06/12/2018] [Accepted: 06/13/2018] [Indexed: 12/27/2022]
Abstract
Mutations and activation of the PI3K signaling pathway in breast cancer cells have been linked to brain metastases. However, here we describe that in some breast cancer brain metastases samples the protein expression of PI3K signaling components is restricted to the metastatic microenvironment. In contrast to the therapeutic effects of PI3K inhibition on the breast cancer cells, the reaction of the brain microenvironment is less understood. Therefore we aimed to quantify the PI3K pathway activity in breast cancer brain metastasis and investigate the effects of PI3K inhibition on the central nervous system (CNS) microenvironment. First, to systematically quantify the PI3K pathway activity in breast cancer brain metastases, we performed a prospective biomarker study using a reverse phase protein array (RPPA). The majority, namely 30 out of 48 (62.5%) brain metastatic tissues examined, revealed high PI3K signaling activity that was associated with a median overall survival (OS) of 9.41 months, while that of patients, whose brain metastases showed only moderate or low PI3K activity, amounted to only 1.93 and 6.71 months, respectively. Second, we identified PI3K as a master regulator of metastasis-promoting macrophages/microglia during CNS colonization; and treatment with buparlisib (BKM120), a pan-PI3K Class I inhibitor with a good blood-brain-barrier penetrance, reduced their metastasis-promoting features. In conclusion, PI3K signaling is active in the majority of breast cancer brain metastases. Since PI3K inhibition does not only affect the metastatic cells but also re-educates the metastasis-promoting macrophages/microglia, PI3K inhibition may hold considerable promise in the treatment of brain metastasis and the respective microenvironment.
Collapse
Affiliation(s)
- Raquel Blazquez
- Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.,Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany
| | - Darius Wlochowitz
- Institute of Bioinformatics, University Medical Center Göttingen, Göttingen, Germany
| | - Alexander Wolff
- Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany
| | - Stefanie Seitz
- Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany
| | - Astrid Wachter
- Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany
| | - Julia Perera-Bel
- Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany
| | - Annalen Bleckmann
- Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany.,Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany
| | - Tim Beißbarth
- Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany
| | - Gabriela Salinas
- Department of Developmental Biochemistry, University Medical Center Göttingen, Göttingen, Germany
| | | | - Martin Proescholdt
- Department of Neurosurgery, University Hospital Regensburg, Regensburg, Germany
| | - Matthias Evert
- Institute of Pathology, University of Regensburg, Regensburg, Germany
| | - Kirsten Utpatel
- Institute of Pathology, University of Regensburg, Regensburg, Germany
| | - Laila Siam
- Institute of Neurosurgery, University Medical Center Göttingen, Göttingen, Germany
| | - Bawarjan Schatlo
- Institute of Neurosurgery, University Medical Center Göttingen, Göttingen, Germany
| | - Marko Balkenhol
- Comprehensive Cancer Center, University Medical Center Göttingen, Göttingen, Germany
| | - Christine Stadelmann
- Institute of Neuropathology, University Medical Center Göttingen, Göttingen, Germany
| | | | - Ulrike Korf
- Division of Molecular Genome Analysis, German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - Eileen Reinz
- Division of Molecular Genome Analysis, German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - Stefan Wiemann
- Division of Molecular Genome Analysis, German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - Elena Vollmer
- Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany
| | - Mathias Schulz
- Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany
| | - Uwe Ritter
- Regensburg Center for Interventional Immunology (RCI), Institute of Immunology, University Hospital Regensburg and University of Regensburg, Regensburg, Germany
| | - Uwe K Hanisch
- Institute of Neuropathology, University Medical Center Göttingen, Göttingen, Germany
| | - Tobias Pukrop
- Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.,Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany
| |
Collapse
|
46
|
Matvienko T, Sokolova V, Prylutska S, Harahuts Y, Kutsevol N, Kostjukov V, Evstigneev M, Prylutskyy Y, Epple M, Ritter U. In vitro study of the anticancer activity of various doxorubicin-containing dispersions. Bioimpacts 2018; 9:57-63. [PMID: 30788260 PMCID: PMC6378100 DOI: 10.15171/bi.2019.07] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/08/2018] [Revised: 09/26/2018] [Accepted: 09/30/2018] [Indexed: 01/30/2023]
Abstract
Introduction: The aim of this research was to study the impact of various doxorubicin (Dox)-containing nanofluids, e.g. singlewalled carbon nanotube (SWCNT)+Dox, graphene oxide (GO)+Dox and DextranPNIPAM (copolymer)+Dox mixtures on HeLa cells (human transformed cervix epithelial cells, as a model for cancer cells) depending on their concentration. Methods: Structural analysis of GO+Dox complex was accomplished using Hartree-Fock level of theory in 6-31G** basis set in Gaussian. Dynamic light scattering (DLS), zeta-potential, scanning electron microscopy and confocal laser scanning microscopy were used. The cell viability was analyzed by the MTT assay. Results: The viability of HeLa cells was studied with the MTT assay after the incubation with various Dox-containing dispersions depending on their concentration. The size of the particles was determined by DLS. The morphology of the nanoparticles (NPs) was studied by scanning electron microscopy and their uptake into cells was visualized by confocal laser scanning microscopy. It was found that the Dextran-PNIPAM+Dox nanofluid in contrast to Dox alone showed higher toxicity towards HeLa cells up to 80% after 24 hours of incubation, whereas the SWCNT+Dox and GO+Dox nanofluids at the same concentrations protected cells from Dox. Conclusion: The importance of Dextran-PNIPAM copolymer as a universal platform for drug delivery was established, and the huge potential of Dextran-PNIPAM+Dox NPs as novel anticancer agents was noted. Based on the in vitro study of the SWCNT+Dox and GO+Dox nanofluids, it was concluded that SWCNT and GO NPs can be effective cytoprotectors against the highly toxic drugs.
Collapse
Affiliation(s)
- Tatiana Matvienko
- Taras Shevchenko National University of Kyiv, Volodymyrska Str., 64, 01601 Kyiv, Ukraine
| | - Viktoriya Sokolova
- Institute of Inorganic Chemistry and Center for Nanointegration Duisburg-Essen (CeNIDE), University of Duisburg-Essen, University Str., 5-7, 45117 Essen, German
| | - Svitlana Prylutska
- Taras Shevchenko National University of Kyiv, Volodymyrska Str., 64, 01601 Kyiv, Ukraine
| | - Yuliia Harahuts
- Taras Shevchenko National University of Kyiv, Volodymyrska Str., 64, 01601 Kyiv, Ukraine
| | - Nataliya Kutsevol
- Taras Shevchenko National University of Kyiv, Volodymyrska Str., 64, 01601 Kyiv, Ukraine
| | - Viktor Kostjukov
- Department of Physics, Sevastopol State University, Universitetskaya Str., 33, 299053 Sevastopol, Crimea
| | - Maxim Evstigneev
- Department of Physics, Sevastopol State University, Universitetskaya Str., 33, 299053 Sevastopol, Crimea
| | - Yuriy Prylutskyy
- Taras Shevchenko National University of Kyiv, Volodymyrska Str., 64, 01601 Kyiv, Ukraine
| | - Matthias Epple
- Institute of Inorganic Chemistry and Center for Nanointegration Duisburg-Essen (CeNIDE), University of Duisburg-Essen, University Str., 5-7, 45117 Essen, German
| | - Uwe Ritter
- Technical University Ilmenau, Institute of Chemistry and Biotechnology, Weimarer Str., 25, 98693 Ilmenau, Germany
| |
Collapse
|
47
|
Tsierkezos NG, Ritter U, Nugraha Thaha Y, Knauer A, Fernandes D, Kelarakis A, McCarthy EK. Boron-doped multi-walled carbon nanotubes as sensing material for analysis of dopamine and epinephrine in presence of uric acid. Chem Phys Lett 2018. [DOI: 10.1016/j.cplett.2018.09.007] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
48
|
Minchenko OH, Tsymbal DO, Minchenko DO, Prylutska SV, Hnatiuk OS, Prylutskyy YI, Tsierkezos NG, Ritter U. Single-walled carbon nanotubes affect the expression of genes associated with immune response in normal human astrocytes. Toxicol In Vitro 2018; 52:122-130. [PMID: 29906516 DOI: 10.1016/j.tiv.2018.06.011] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2018] [Revised: 06/02/2018] [Accepted: 06/08/2018] [Indexed: 12/11/2022]
Abstract
The effect of single-walled carbon nanotubes (SWCNTs) on the expression of a subset of immune response, apoptosis and cell proliferation -associated genes was studied in normal human astrocytes (line NHA/TS). In the cells treated with SWCNTs (2, 10 and 50 ng/ml of medium for 24 h) we observed a strong dose-dependent down-regulation of the expression of a cell surface glycoproteins HLA-DRA (major histocompatibility complex, class II, DR alpha) and HLA-DRB1. At the same time, the expression of HLA-F (major histocompatibility complex, class I, F), LMNB1 (lamin B1), and HTRA1 (high temperature requirement A1) genes as well as the level of miR-190b and miR-7 was up-regulated in NHA/TS subjected to different concentrations of SWCNTs. After 24 h of treatment with SWCNTs we detected a dose-dependent suppression of PHLDA2 (pleckstrin homology-like domain, family A, member 2) gene expression in these cells. Obtained data show that SWCNTs may affect an immune response, in particular through suppression of HLA-DRA and HLA-DRB1 gene expressions and that miR-190b and miR-7 possibly participated in this suppression. Deregulation of lamin B1 expression indicates the possibility of alterations in genome stability following treatment of astrocytes with SWCNTs. Thus, more caution is needed in biomedical application of SWCNTs.
Collapse
Affiliation(s)
- Oleksandr H Minchenko
- Department of Molecular Biology, Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine, 9 Leontovycha Str, Kyiv 01601, Ukraine.
| | - Dariia O Tsymbal
- Department of Molecular Biology, Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine, 9 Leontovycha Str, Kyiv 01601, Ukraine
| | - Dmytro O Minchenko
- Department of Molecular Biology, Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine, 9 Leontovycha Str, Kyiv 01601, Ukraine; Department of Pediatrics, Bohomolets National Medical University, 13 Taras Shevchenko Blvd., Kyiv 01601, Ukraine
| | - Svitlana V Prylutska
- Taras Shevchenko National University of Kyiv, 64 Volodymyrska Str, 01601 Kyiv, Ukraine
| | - Oksana S Hnatiuk
- Department of Molecular Biology, Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine, 9 Leontovycha Str, Kyiv 01601, Ukraine
| | - Yuriy I Prylutskyy
- Taras Shevchenko National University of Kyiv, 64 Volodymyrska Str, 01601 Kyiv, Ukraine
| | - Nikos G Tsierkezos
- Technische Universität Ilmenau, Institut für Chemie und Biotechnik, 25 Weimarer Str., 98693 Ilmenau, Germany.
| | - Uwe Ritter
- Technische Universität Ilmenau, Institut für Chemie und Biotechnik, 25 Weimarer Str., 98693 Ilmenau, Germany
| |
Collapse
|
49
|
Grebinyk A, Grebinyk S, Prylutska S, Ritter U, Matyshevska O, Dandekar T, Frohme M. C 60 fullerene accumulation in human leukemic cells and perspectives of LED-mediated photodynamic therapy. Free Radic Biol Med 2018; 124:319-327. [PMID: 29940354 DOI: 10.1016/j.freeradbiomed.2018.06.022] [Citation(s) in RCA: 37] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/22/2018] [Revised: 05/29/2018] [Accepted: 06/20/2018] [Indexed: 12/26/2022]
Abstract
Recent progress in nanobiotechnology has attracted interest to a biomedical application of the carbon nanostructure C60 fullerene since it possesses a unique structure and versatile biological activity. C60 fullerene potential application in the frame of cancer photodynamic therapy (PDT) relies on rapid development of new light sources as well as on better understanding of the fullerene interaction with cells. The aim of this study was to analyze C60 fullerene effects on human leukemic cells (CCRF-CEM) in combination with high power single chip light-emitting diodes (LEDs) light irradiation of different wavelengths: ultraviolet (UV, 365 nm), violet (405 nm), green (515 nm) and red (632 nm). The time-dependent accumulation of fullerene C60 in CCRF-CEM cells up to 250 ng/106 cells at 24 h with predominant localization within mitochondria was demonstrated with immunocytochemical staining and liquid chromatography mass spectrometry. In a cell viability assay we studied photoexcitation of the accumulated C60 nanostructures with ultraviolet or violet LEDs and could prove that significant phototoxic effects did arise. A less pronounced C60 fullerene phototoxic effect was observed after irradiation with green, and no effect was detected with red light. A C60 fullerene photoactivation with violet light induced substantial ROS generation and apoptotic cell death, confirmed by caspase3/7 activation and plasma membrane phosphatidylserine externalization. Our work proved C60 fullerene ability to induce apoptosis of leukemic cells after photoexcitation with high power single chip 405 nm LED as a light source. This underlined the potential for application of C60 nanostructure as a photosensitizer for anticancer therapy.
Collapse
Affiliation(s)
- Anna Grebinyk
- Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745 Wildau, Germany; Dept. of Bioinformatics, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany; Educational and Scientific Center "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Volodymyrska 64, 01601 Kyiv, Ukraine
| | - Sergii Grebinyk
- Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745 Wildau, Germany
| | - Svitlana Prylutska
- Dept. of Chemistry, Taras Shevchenko National University of Kyiv, Volodymyrska 64, 01601 Kyiv, Ukraine
| | - Uwe Ritter
- Institute of Chemistry and Biotechnology, University of Technology Ilmenau, Weimarer Straße 25 (Curiebau), 98693 Ilmenau, Germany
| | - Olga Matyshevska
- Educational and Scientific Center "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Volodymyrska 64, 01601 Kyiv, Ukraine
| | - Thomas Dandekar
- Dept. of Bioinformatics, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany
| | - Marcus Frohme
- Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745 Wildau, Germany.
| |
Collapse
|
50
|
Vereshchaka IV, Bulgakova NV, Maznychenko AV, Gonchar OO, Prylutskyy YI, Ritter U, Moska W, Tomiak T, Nozdrenko DM, Mishchenko IV, Kostyukov AI. C 60 Fullerenes Diminish Muscle Fatigue in Rats Comparable to N-acetylcysteine or β-Alanine. Front Physiol 2018; 9:517. [PMID: 29867560 PMCID: PMC5962757 DOI: 10.3389/fphys.2018.00517] [Citation(s) in RCA: 44] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2018] [Accepted: 04/20/2018] [Indexed: 12/12/2022] Open
Abstract
The aim of this study is to detect the effects of C60 fullerenes, which possess pronounced antioxidant properties, in comparison with the actions of the known exogenous antioxidants N-acetylcysteine (NAC) and β-Alanine in terms of exercise tolerance and contractile property changes of the m. triceps surae (TS) during development of the muscle fatigue in rats. The electrical stimulation of the TS muscle during four 30 min series in control rats led to total reduction of the muscle contraction force. Furthermore, the effects of prior intraperitoneal (i.p.) or oral C60FAS application and preliminary i.p. injection of NAC or β-Alanine on muscle contraction force under fatigue development conditions is studied. In contrast to control rats, animals with C60FAS, NAC, or β-Alanine administration could maintain a constant level of muscle effort over five stimulation series. The accumulation of secondary products and changes in antioxidant levels in the muscle tissues were also determined after the fatigue tests. The increased levels of lactic acid, thiobarbituric acid reactive substances and H2O2 after stimulation were statistically significant with respect to intact muscles. In the working muscle, there was a significant (p < 0.05) increase in the activity of endogenous antioxidants: reduced glutathione, catalase, glutathione peroxidase, and superoxide dismutase. Treated animal groups showed a decrease in endogenous antioxidant activity relative to the fatigue-induced animals (P < 0.05). Oral C60FAS administration clearly demonstrated an action on skeletal muscle fatigue development similar to the effects of i.p. injections of the exogenous antioxidants NAC or β-Alanine. This creates opportunities to oral use of C60FAS as a potential therapeutic agent. Due to the membranotropic activity of C60 fullerenes, non-toxic C60FAS has a more pronounced effect on the prooxidant-antioxidant homeostasis of muscle tissues in rats.
Collapse
Affiliation(s)
- Inna V. Vereshchaka
- The Unit of the Theory of Physical Education, The Chair of Physical Education, Gdansk University of Physical Education and SportGdańsk, Poland
| | - Nataliya V. Bulgakova
- Department of Movement Physiology, Bogomoletz Institute of Physiology, National Academy of Sciences, Kyiv, Ukraine
| | - Andriy V. Maznychenko
- Department of Movement Physiology, Bogomoletz Institute of Physiology, National Academy of Sciences, Kyiv, Ukraine
| | - Olga O. Gonchar
- Department of Hypoxic States Investigation, Bogomoletz Institute of Physiology, National Academy of Sciences, Kyiv, Ukraine
| | - Yuriy I. Prylutskyy
- ESC “Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Kyiv, Ukraine
| | - Uwe Ritter
- Institute of Chemistry and Biotechnology, Technical University of Ilmenau, Ilmenau, Germany
| | - Waldemar Moska
- The Unit of the Theory of Physical Education, The Chair of Physical Education, Gdansk University of Physical Education and SportGdańsk, Poland
| | - Tomasz Tomiak
- The Unit of the Theory of Physical Education, The Chair of Physical Education, Gdansk University of Physical Education and SportGdańsk, Poland
| | - Dmytro M. Nozdrenko
- ESC “Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Kyiv, Ukraine
| | | | - Alexander I. Kostyukov
- Department of Movement Physiology, Bogomoletz Institute of Physiology, National Academy of Sciences, Kyiv, Ukraine
| |
Collapse
|